US 9,730,791 B2Grant
Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
Issue Date:2017-08-15
•26 Claims
•6 Drawing Sheets
Abstract
A prosthesis can comprise an expandable frame, a plurality of distal anchors and a plurality of proximal anchors. The anchors can extend outwardly from the frame. The frame can be configured to radially expand and contract for deployment within a body cavity. The frame and anchors can have one of many different shapes and configurations. For example, when the frame is in an expanded configuration, the proximal anchors can extend a significant distance away from the exterior of the frame, such as a length equal to or greater than about one half the diameter of the frame. As another example, the anchors can have looped ends.
Metadata
Assignee
- Edwards Lifesciences CardiAQ LLC
Inventors
- J. Brent Ratz
- Arshad Quadri
- Luca Pesce
Application Information
Application Number:US 14/197,590
Filing Date:2014-03-05
Priority Date:2013-03-14
Art Unit:3738
Classifications
IPC:
A61F2/24
Field of Search:
A61F 2/24A61F 2/2409
Patent Drawings (6 sheets)
Description
Cross-Reference to Related Applications
[0001] This application claims the benefit of priority to U.S. Provisional Appl. No. 61/782,707, filed Mar. 14, 2013, 61/789,783, filed Mar. 15, 2013, and 61/798,115 filed Mar. 15, 2013. The entire contents of the above applications are hereby incorporated by reference and made a part of this specification. Any and all priority claims identified in the Application Data Sheet, or any correction thereto, are hereby incorporated by reference under 37 CFR 1.57.
Background of the Invention
[0002] Field of the Invention
[0003] Certain embodiments disclosed herein relate generally to prostheses for implantation within a lumen or body cavity. In particular, certain embodiments relate to expandable prostheses such as replacement heart valves, such as for the mitral valve, that are configured to atraumatically grasp intralumenal tissue.
[0004] Description of the Related Art
[0005] Human heart valves, which include the aortic, pulmonary, mitral and tricuspid valves, function essentially as one-way valves operating in synchronization with the pumping heart. The valves allow blood to flow downstream, but block blood from flowing upstream. Diseased heart valves exhibit impairments such as narrowing of the valve or regurgitation, which inhibit the valves' ability to control blood flow. Such impairments reduce the heart's blood-pumping efficiency and can be a debilitating and life threatening condition. For example, valve insufficiency can lead to conditions such as heart hypertrophy and dilation of the ventricle. Thus, extensive efforts have been made to develop methods and apparatuses to repair or replace impaired heart valves.
[0006] Prostheses exist to correct problems associated with impaired heart valves. For example, mechanical and tissue-based heart valve prostheses can be used to replace impaired native heart valves. More recently, substantial effort has been dedicated to developing replacement heart valves, particularly tissue-based replacement heart valves that can be delivered with less trauma to the patient than through open heart surgery. Replacement valves are being designed to be delivered through minimally invasive procedures and even percutaneous procedures. Such replacement valves often include a tissue-based valve body that is connected to an expandable frame that is then delivered to the native valve's annulus.
[0007] Development of prostheses including but not limited to replacement heart valves that can be compacted for delivery and then controllably expanded for controlled placement has proven to be particularly challenging. An additional challenge relates to the ability of such prostheses to be secured relative to intralumenal tissue, e.g., tissue within any body lumen or cavity, in an atraumatic manner. These replacement valves are often intended to at least partially block blood flow. However, a problem occurs when blood flows around the valve on the outside of the prosthesis. For example, in the context of replacement heart valves, paravalvular leakage has proven particularly challenging.
Summary of the Invention
[0008] Embodiments of the present disclosure are directed to a prosthesis, such as but not limited to a replacement heart valve. In some embodiments a prosthesis can comprise an expandable frame, a plurality of distal anchors and a plurality of proximal anchors. The anchors can extend outwardly from the frame. The frame can be configured to radially expand and contract for deployment within the body cavity. When the frame is in an expanded configuration, the proximal anchors can extend a significant distance away from the exterior of the frame, such as a length of about one-half or more the diameter of the frame. In some embodiments, at least some of the anchors comprise a loop that forms an atraumatic end of a corresponding anchor. In some embodiments, an outer skirt may be positioned annularly around an exterior of the expandable frame and be connected to some of the anchors to create an axial barrier to fluid flow exterior to the frame when deployed within the body cavity.
[0009] Further embodiments are directed to methods of delivering a prosthesis, e.g. a replacement heart valve, methods of securing a prosthesis to intralumenal tissue, and methods of using a prosthesis to create a barrier to fluid flow exterior to the prosthesis (e.g., to prevent paravalvular leakage).
[0010] In some embodiments, a prosthesis can be configured to grasp intralumenal tissue when deployed within a body cavity. The prosthesis can comprise an expandable frame, a plurality of proximal anchors connected to the frame, and a plurality of distal anchors connected to the frame. The expandable frame can comprise a proximal end and a distal end and a longitudinal axis extending therethrough, the frame configured to collapse radially for delivery and to expand radially upon deployment. The plurality of proximal anchors can be expandable to a configuration wherein a portion of each of the proximal anchors extends generally distally and an end of each of the proximal anchors is positioned radially outward from the frame. The plurality of distal anchors can be expandable to a configuration wherein a portion of each of the distal anchors extends generally proximally and an end of each of the distal anchors is positioned radially outward from the frame. Expansion of the frame from a first at least partially collapsed size to a second expanded size can cause the ends of the proximal anchors and the ends of the distal anchors to draw closer together. At least some of the plurality of proximal anchors can be configured to expand to a radial distance from a central longitudinal axis of the frame that is about 150% or more of a radius of the frame when the frame is in an expanded configuration.
Brief Description of the Drawings
[0011] These and other features, aspects and advantages are described below with reference to the drawings, which are intended to illustrate but not to limit the invention. In the drawings, like reference characters denote corresponding features consistently throughout similar embodiments.
[0012] FIG. 1 is a side view of a frame for a prosthesis.
[0013] FIG. 2 is an embodiment of a prosthesis configured as a replacement heart valve.
[0014] FIG. 3 is an embodiment of a prosthesis configured as a replacement heart valve.
[0015] FIG. 4 is an embodiment of a prosthesis configured as a replacement heart valve.
[0016] FIG. 5 is a schematic representation of a prosthesis positioned within the heart.
[0017] FIG. 6 is a detail schematic representation of the prosthesis positioned within the heart of FIG. 5 .
Detailed Description of the Preferred Embodiments
[0018] The present specification and drawings provide aspects and features of the disclosure in the context of several embodiments of prostheses, replacement heart valves, delivery devices and methods that are configured for use in the vasculature of a patient, such as for replacement of natural heart valves in a patient. These embodiments may be discussed in connection with replacing specific valves such as the patient's aortic or mitral valve. However, it is to be understood that the features and concepts discussed herein can be applied to products other than heart valve implants. For example, the controlled positioning, deployment, and securing features described herein can be applied to medical implants, for example other types of expandable prostheses, for use elsewhere in the body, such as within a vein, or the like. In addition, particular features of a valve, delivery device, etc. should not be taken as limiting, and features of any one embodiment discussed herein can be combined with features of other embodiments as desired and when appropriate.
[0019] With initial reference to FIG. 1 , an embodiment of a prosthesis 10 is shown. The illustrated prosthesis 10 includes a frame 20 that may be self-expanding or balloon expandable. The frame 20 can include a proximal end 32, a distal end 34 and proximal 22 and distal 24 anchors. The anchors can allow the frame to engage a native valve annulus or other tissue to be implanted at a target location. The prosthesis 10 can include one or more of a valve 60, an outer skirt 30, and a valve skirt 70 as will be described in more detail below. The valve 60 can be designed to replace a damaged or diseased native heart valve such as a mitral valve; though it will be understood that a replacement valve is not required as part of the prosthesis.
[0020] The prosthesis can be a replacement heart valve similar to that and including features similar to those disclosed in U.S. Provisional Appl. No. 61/782,707, filed Mar. 14, 2013 and 61/789,783 filed Mar. 15, 2013, U.S. Pat. No. 8,403,983 and U.S. Publication Nos. 2010/0298931, 2011/0313515 and 2012/0078353 the entireties of each of which are hereby incorporated by reference and made a part of this specification. This is inclusive of the entire disclosure and is not in any way limited to the disclosure of the replacement heart valve.
[0021] The frame 20 can be made of many different materials, but is preferably made from metal. In some embodiments, the frame 20 can be made from a shape memory material, such as nitinol. A wire frame or a metal tube can be used to make the frame. The wire frame of a metal tube can be cut or etched to remove all but the desired metal skeleton. In some embodiments a metal tube is laser cut in a repeating pattern to form the frame. The flat pattern can be cut from a metal tube and then the tube can be bent and expanded to the shape shown in FIG. 1 . The frame 20 can further be expanded and/or compressed and/or otherwise worked to have the desired shape or shapes, such as for introduction and implantation.
[0022] As shown, the frame when in an expanded configuration, such as in a fully expanded configuration, has a cylindrical or slightly cylindrical shape, where a middle portion is substantially similar in shape and size as the proximal 32 and distal 34 ends. The frame can be a substantially cylindrical shape with the same or substantially the constant cross-sectional dimension or diameter from the proximal end to the distal end. The cylindrical shape of the frame, in combination with the anchors described below, can advantageously allow the frame to float within a native valve while the anchors engage a native valve annulus or other body cavity and spacing the inlet and outlet of the frame away from the heart or vessel wall. This can help reduce undesired contact between the prosthesis and the heart or vessel, such as the ventricular wall of the heart. The prosthesis 10 and frame 20 may be similar to the replacement heart valves and associated frames disclosed in U.S. Provisional Appl. No. 61/782,707, filed Mar. 14, 2013 and 61/789,783 filed Mar. 15, 2013, U.S. Pat. No. 8,403,983 and U.S. Publication Nos. 2010/0298931 and 2011/0313515 the entireties of each of which are hereby incorporated by reference and made a part of this specification. This is inclusive of the entire disclosure and is not in any way limited to the disclosure of the replacement heart valves and associated frames.
[0023] A number of struts collectively make up the frame 20. FIG. 1 illustrates the frame in an expanded configuration with a number of longitudinal struts 12 and undulating struts 14, with cells 16, 18 defined by the open spaces between the struts. The longitudinal struts may be arranged so that they are parallel or generally or substantially parallel to a longitudinal axis of the frame. The longitudinal axis of the frame may be defined as the central axis that extends through the center of the frame between the proximal 32 and distal 34 ends. Any number of configurations of struts can be used, such as the rings of undulating struts shown forming chevrons and diamonds, but also ovals, curves, and various other shapes. The illustrated embodiment includes two rows of diamond-shaped cells 16 at the top or adjacent the proximal end and then a row of sideways diamond-shaped cells 18 at the bottom or near the distal end. These sideways diamond-shapes are made of two longitudinal struts 12 that are offset from one another, or one is higher than the other, and then an undulating strut 14 connects the longitudinal struts 12 at the top and bottom of the cell. The sideways diamond-shapes alternate between sides as to which side is higher and which is lower. So a first sideways diamond-shaped cell 18A has a low left side and a high right side, and a second sideways diamond-shaped 18B had a high left side and a low right side, where the high right side of cell 18A shares the same longitudinal strut 12 as the high left side of cell 18B.
[0024] Some of the struts can include one or more eyelet 46. As illustrated, a plurality of eyelets, here five, are located along one of the longitudinal struts 12 as part of the sideways diamond-shaped cells. One or more eyelets can be positioned in other locations along the frame and/or anchors. The eyelets 46 may be used to attach features such as the valve 60, outer skirt 30, and/or valve skirt 70 to the frame 20.
[0025] The frame 20 as illustrated is foreshortening. The foreshortening can be defined by the frame 20 and the positioning of various types of struts along the frame 20. When the frame is radially collapsed or compacted, the struts 14 become more parallel with respect to the longitudinal axis of the frame, causing cells 16 and 18 to collapse, causing an outer diameter of the frame to decrease and the longitudinal length of the frame to increase. As the frame moves from a compacted position to an expanded position, the cells 16 and 18 widen sideways and the longitudinal length of the frame can decrease. It will be appreciated while in some embodiments the entire length of the frame 20 is foreshortening, in other embodiments such as embodiments of the prostheses described in the patents and applications incorporated by reference herein, only a portion of the frame is foreshortening.
[0026] Foreshortening of the frame 20 can be used to engage and secure the prosthesis to intralumenal tissue in a body cavity, for example tissue at or adjacent a native valve, such as a native valve annulus and/or leaflets. Opposing anchors 22, 24 can be constructed on the frame 20 so that portions of the anchors, such as tips or ends 26, 28, move closer together as the frame foreshortens. As one example, this can allow the anchors 22, 24 to grasp tissue on opposite sides of the native mitral annulus to thereby secure the prosthesis at the mitral valve.
[0027] The anchors 22, 24 and anchor tips 26, 28 can be located anywhere along the frame 20 just so long as at least one of the anchors is either connected to a foreshortening portion or a foreshortening portion is positioned between the anchors so that a portion of the anchors will be move closer together with expansion of the frame. As shown in FIG. 1 , the foreshortening portion extends the entire or substantially the entire length of the frame.
[0028] Preferably, each of the anchors 22, 24 is positioned or extends generally radially outwardly from the frame 20 so that the anchor tips 26, 28 are generally spaced away or radially outward from the rest of the frame 20. For example, the anchor tips may be located radially outward from the middle portion of the frame, with the tips 26 and 28 being axially spaced from one another. In some embodiments, all or part of the structure connected to the anchor tip and extending radially from the frame, including one or more rings and/or struts, can be considered part of the anchor. The anchors can include a base located on the anchor on a side opposite the tip. The base can be for example where the anchor begins to extend from or away from the frame 20.
[0029] For example, the distal anchors 24 are shown having looped anchors. Each looped anchor has a first base 42 and a second base 44 connected to the frame, wherein the first and second bases are at the distal-most corners of adjacent cells. Alternatively, the first and second bases may be located at adjacent corners of the same cell, or at opposite corners of the same cell if for example the cells adjacent the distal end of the frame have the same configuration as the cells shown in FIG. 1 at the proximal end of the frame. The distal anchors 24 extend generally distally away from the frame and are bent near the base 42 to extend radially outward away from the frame along a first segment 50. Then the anchor is bent to point proximally or generally proximally along a second segment 52 ending in the tip 28. The tips 28 of the distal anchors may be curved or arcuate atraumatic tips. The ends of the distal anchors can extend proximally and be parallel or substantially parallel with the longitudinal axis of the frame, or they may extend generally proximally but still radially outwardly inclined or at an acute angle relative to the longitudinal axis of the frame. The distal anchor 24 then repeats this configuration in reverse towards the second base 44 such that the two sides of the looped anchor are mirror images of one another.
[0030] In addition, as illustrated in FIG. 1 , adjacent distal anchors share one strut so that each distal anchor is directly adjacent another distal anchor. In other embodiments, distal anchors can be spaced apart, for example with at least a cell 18 or two cells 18 located between the distal anchors. It will be understood that the distal anchors can have other configurations such as described in the applications included in the appendix and that the distal anchors may not be symmetrical.
[0031] The proximal anchors 22 are shown having looped anchors of a similar shape and configuration as the distal anchors 24. It can be seen that each proximal anchor extends from or near the proximal end of the frame at bases 54 and 56 located on adjacent proximal-most corners of cells 16. In the embodiment illustrated in FIG. 1 , the proximal anchors are longer than the distal anchors, and as such, the proximal anchors may extend further away from the frame. As shown the anchors extend proximally at the bases 54, 56 and are then bent to segment 58 which extends radially outwardly away from the frame in a generally distal direction. Then the proximal anchor is bent to point distally or generally distally along a second segment 60 ending in the tip 26. The tips 26 of the proximal anchors may be curved or arcuate atraumatic tips. The ends of the proximal anchors can extend distally and be parallel or substantially parallel with the longitudinal axis of the frame, or they may extend generally distally but still radially outwardly inclined or at an acute angle relative to the longitudinal axis of the frame. Another embodiment, described below with respect to FIG. 6 , has the ends of the proximal anchors becoming perpendicular to the longitudinal axis of the frame.
[0032] In addition, adjacent proximal anchors can share the same base where the anchors are bent outward from the frame, or may be considered to extend from the same corner on cell 16. In other embodiments, proximal anchors can be spaced apart so that there is at least a ½ cell or one cell located between the proximal anchors. It will be understood that the proximal anchors can have other configurations such as described in the applications included in the appendix and that the proximal anchors may not be symmetrical. As illustrated in FIG. 1 , between the bases 54 and 56 of each proximal anchor, there may also be located a longitudinally extending strut 80 extending proximally, e.g. from the proximal-most corner of a cell 16 in the second row of cells from the proximal end. These struts 80 may terminate at their proximal ends in an enlarged portion such as a tab 8 that may facilitate holding or retaining the proximal end of the frame, such as in a delivery system as described below.
[0033] In some embodiments, in an expanded state such as shown in FIG. 1 , at least some of the proximal anchors can extend to a radial distance from an exterior surface of the frame that is ½ (or about ½) or more of the expanded diameter of the frame. In some embodiments, all of the proximal anchors extend at least to this radial distance. In even further embodiments, all of the proximal and distal anchors extend at least to this radial distance. In other embodiments, the radial distance of one or more of the ends of the anchors from a central longitudinal axis passing through the middle of the frame may be 150% (or about 150%) or more, 180% (or about 180%) or more, 200% (or about 200%) or more, 220% (or about 220%) or more, or 250% (or about 250%) or more of the radius of the frame when the frame and the anchors are in expanded configurations. For example, if the radius of the frame is 16 mm and a proximal anchor end is spaced 9 mm from the exterior of the frame, that proximal anchor extends 25 mm from the central longitudinal axis of the frame, and is 156.25% of the radius of the frame.
[0034] In some embodiments the diameter of the frame 20 may be in the range of 20-40 mm (or about 20 to about 40 mm), more preferably 25-35 mm (or about 25 to about 35 mm) when expanded. The outermost tip diameter may be greater than the frame diameter as described above and may be in the range of 40-60 mm (or about 40 to about 60 mm), and in some embodiments may be about 50 mm when the frame diameter is about 30 mm. In some embodiments the length of the prosthesis, from proximal to distal end, when compressed, is between 20-40 mm (or about 20 to about 40 mm), more preferably 25 to 30 mm (or about 25 to about 30 mm), for example about 29 mm. When expanded, the prosthesis may have a length between 15 to 20 mm (or about 15 to 20 mm), more preferably 17 to 18 mm (or about 17 to about 18 mm).
[0035] The distal anchors 24 can be positioned to be not as far radially outward as the proximal anchors, and the tips 28 may be positioned radially inward of the tips 26. As described further below, such a configuration may be advantageous in positioning and securing the prosthesis in a mitral valve or other body location. In some embodiments, as illustrated in FIG. 1 , the ends or tips 26 of the proximal anchors 22 are positioned further radially outward from the frame 20 than the ends of tips 28 distal anchors 24 when the frame and the anchors are in an expanded configuration, e.g., when they are fully expanded. In other embodiments, the distal anchors and proximal anchors can be positioned at the same radial outward dimension, or the distal anchors may even be positioned further outward than the proximal anchors. In further embodiments, some of the proximal anchors (or distal anchors) may extend to a first radial distance, and others of the proximal anchors (or distal anchors) may extend to a second radial distance, where the first radial distance is greater than the second radial distance. The distal anchors in FIG. 1 are shown to be circumferentially staggered with respect to the proximal anchors, meaning that the tips 26 of the proximal anchors are not aligned, and are circumferentially in between the tips 28 of the distal anchors. In other embodiments, the tips 26 and 28 may be circumferentially aligned.
[0036] It will be understood that the anchors can have various other configurations. In some embodiments, each of the anchors can extend radially outwardly from the frame at an anchor base and terminate at an anchor tip. The anchors can be connected to the frame at one of many different locations including apices, junctions, other parts of struts, etc. The anchors can comprise first, second, third, or more spaced apart bending stages along the length of each anchor. The anchors can also extend either distally or proximally before and/or after one or more of the bending stages. A portion of the anchor may extend with the frame before or after any bending stages. As shown, the anchors 22, 24 may comprise loops as described above, having a curved or arcuate atraumatic tip to minimize damage to body tissue. Further details that may be incorporated and/or interchanged with the features described herein are disclosed in U.S. Provisional Appl. No. 61/782,707, filed Mar. 14, 2013 and 61/789,783 filed Mar. 15, 2013, U.S. Pat. No. 8,403,983 and U.S. Publication Nos. 2010/0298931, 2011/0313515 and 2012/0078353, incorporated by reference herein.
[0037] In one embodiment the prosthesis has nine distal anchors and nine proximal anchors. Any number of proximal and distal anchors may be used. In other embodiments, instead of a 1:1 correspondence between anchors, other ratios, such as a 9:6 or a 9:3 correspondence between the anchors, are possible.
[0038] With respect to the number of cells and rows of cells, when there are nine proximal anchors and nine distal anchors, there may be two rows of nine cells 16 each. The cells in the second row can share struts 14 from the first row. A third row at the distal end can have a different cell configuration with sideways diamonds as illustrated in FIG. 1 , and can for example have eighteen cells 18, with each cell 18 sharing a strut from a cell in the second row. In other embodiments, the third row can include cells similar in shape to cells 16 in the first and second rows. In another embodiment, a frame may have one or more rows of diamond-shaped cells, where the number of cells per row is 12 or some other number.
[0039] The anchor tips 26 and 28 as described above advantageously provide atraumatic surfaces that may be used to grasp intralumenal tissue without causing unnecessary or undesired trauma to tissue. For example, the proximal anchors tips 26 and distal anchor tips 28 may form flat, substantially flat, curved or other non-sharp surfaces to allow the tips to engage and/or grasp tissue, without necessarily piercing or puncturing through tissue. A looped end or looped anchor may assist the frame in not getting caught up on structures at or near the treatment location. For example, each loop can be configured so that when the frame is deployed in-situ and the anchors expand away from the frame, the movement of each loop from a delivered position to a deployed position avoids getting caught on the papillary muscles.
[0040] The prosthesis 10 may include a valve 60 as can be seen in schematically in FIG. 6 . The valve 60 can be a replacement heart valve which includes a plurality of valve leaflets. The plurality of valve leaflets can function in a manner similar to the natural mitral valve, or to other valves in the vascular system. The plurality of valve leaflets can open in a first position and then engage one another to close the valve in a second position. The plurality of valve leaflets can be made to function as a one way valve such that flow in one direction opens the valve and flow in a second direction opposite the first direction closes the valve. The replacement heart valve 60 can be constructed so as to open naturally with the beating of the heart. For example, the plurality of valve leaflets can open during diastole and close during systole.
[0041] In some embodiments, the leaflets can be coupled to a valve skirt 70. For example, FIG. 2 shows a seam 62 where the proximal ends of the leaflets can be connected to the valve skirt 70.
[0042] The valve skirt 70 can be used to at least partially control how fluid flows through and/or around the valve 60. The valve skirt 70 can surround at least a portion of the valve and be connected to the valve leaflets. In some embodiments, the valve skirt 70 can form an inner wall connected to and positioned within the frame 20. For example the skirt 70 can connect to the frame at the eyelets 46, such as by stitching. The skirt may also be attached directing to the struts, typically also by stitching. The valve skirt 70 can also be made to move with the foreshortening portion of the frame 20.
[0043] The valve skirt 70 can extend the length of the frame 20 or it can extend along only part of the length of the frame 20. In some embodiments, the ends of the heart valve 60 can coincide with ends of the valve skirt 70. In addition, one or more of the ends of the frame 20 can coincide with the ends of the valve skirt 70. In the illustrated embodiment of FIG. 2 , the proximal end of the valve skirt 70 is positioned proximally from the proximal end of the heart valve 60 as indicated by the seam 62. The valve skirt 70 can not only extend to the distal end of the frame 20 but can also extend to the outside of the frame and is shown attached to and extending to the tip 28 of each distal anchor 24. As shown, the skirt 70 is sewn to each distal anchor.
[0044] Other shapes and configurations can also be used for the valve 60 and valve skirt 70. In some embodiments, the valve skirt 70 may extend along the length of the leaflets, but is not connected to them. In the illustrated embodiments, the valve skirt 70 is attached to the frame 20 and the leaflets are attached to the valve skirt 70, such as at the seam 62 in FIG. 2 .
[0045] The valve skirt 70 can be constructed in multiple different ways. The valve skirt 70 can be made a layer of resilient material, such as knit polyester or another stretchable or flexible fabric. In some embodiments, the valve skirt 70 is made from a material that is more flexible than the valve leaflet material. The distal and/or proximal end of the skirt 70 can be straight, curved, or have any other desired configuration. For example, the valve skirt 70 is shown with a straight proximal end at the proximal end 32 of the frame. In other embodiments the skirt distal end can be patterned to generally correspond to the undulations at one end of the frame 20. The valve skirt 70 can be formed of one piece or multiple pieces. For example, the valve skirt 70 attached to the valve 60 can be one piece and then each distal anchor can be covered by a separate piece of material of the valve skirt 70. It is to be understood that other configurations of the valve skirt 70 can also be employed. For example, the anchors may remain uncovered, or only a portion may be covered.
[0046] In another embodiment of the valve skirt 70, the end can extend past the frame and can be wrapped around it. Thus, the valve skirt 70 can extend from the inside of the frame 20 to the outside of the frame. The skirt can extend completely around the frame for ¼, ⅓, ½, or more of the length of the distal anchors. Such an embodiment is shown and described with respect to FIGS. 7A-7B of Provisional Appl. No. 61/782,707. The skirt 70 can also cover the distal anchors 24 as is shown in FIGS. 7A and 7B of Provisional Appl. No. 61/782,707 and in FIG. 2 herein. The skirt can be a one piece skirt, but it will be understood that the skirt can be made of multiple pieces.
[0047] The valve skirt 70, and particularly portions that cover the distal anchors 24, can beneficially be used to help prevent leakage of blood flow around the heart valve. In addition, the skirt can encourage tissue in-growth between the skirt and the natural tissue. This may further help to prevent leakage of blood flow around the heart valve.
[0048] Continuing to look to FIG. 2 , an outer skirt or apron 30 is shown that may also form part of the prosthesis 10. FIG. 2 shows the outer skirt 30 attached to the frame 20 at the tips 26 of the proximal anchors. The outer skirt 30 can have a portion shaped to correspond generally with the shape of an outer portion of the frame 20. For example, a first portion 64 of the outer skirt 30 can have a cylindrical or generally cylindrical shape with an inner diameter that substantially corresponds in size to, or may be larger or slightly larger than, an outer diameter of the frame 20. The outer skirt 30 can have a second portion 66 with an annular shape that extends away from the first portion 64 to an outer border with a diameter larger than the diameter of the first portion. As illustrated in FIG. 2 , the second portion 66 is shown flaring outward from the first portion 64 and extending generally perpendicularly from the first portion 64. Thus, the illustrated second portion forms an annular ring comprising a proximal edge and a distal edge, wherein a diameter of the proximal edge is larger than a diameter of the distal edge.
[0049] The outer skirt 30 can attach to the frame, and more preferably attach to the anchors, in one of many different ways. The outer skirt 30 can be sewn to the frame and/or valve skirt. The outer skirt 30 can also be wrapped around a portion of the frame and then sewn to itself. In the embodiment illustrated in FIG. 2 , the second portion 66 is attached to the proximal anchors 22. For example, a plurality of circumferentially spaced tabs 68 extending radially outward from the proximal edge of the second portion 66 can be used to attach the outer skirt 30 to the proximal anchors. The tabs 68 can be wrapped around the tip 26 (e.g., through the loop) of a proximal anchor and connected to the second portion. The tabs 68 themselves may also form sleeves that are configured to surround at least a portion of the proximal anchors. In some embodiments, the proximal anchors 22 can include eyelets that may be used to secure the skirt to the anchor. The tab 68 can be attached to the eyelet 46, for example by stitching.
[0050] In one embodiment, the outer skirt 30 is only attached to the frame via the proximal anchors, and the first portion 64 remains unattached to any portion of the frame or any anchors. In another embodiment, the outer skirt is both attached to the proximal anchors and to the middle portion of the frame. As illustrated in FIG. 2 , the second portion 66 attached to the anchors extends inwardly from the proximal anchors 22. The first portion 64 then extends distally from the second portion 66 and terminates in a distal edge, which may be free or which may attach to the middle portion of the frame 20 or the skirt 70. In other embodiments, the first portion 64 may also be attached to portions of the frame and/or the distal anchors. In some embodiments, the distal edge of the skirt 30 may be spaced radially outward from the frame when the frame is in an expanded configuration. In addition, the distal edge of the skirt 30 may extend to the distal end of the frame, or it may be spaced proximally therefrom as illustrated in FIG. 2 .
[0051] In some embodiments, the outer skirt 30 can attach to the frame at a distal end of the skirt, or at some other location and then curve up and out towards the proximal anchors. Thus, the outer skirt may not have a distinct first portion and second portion. In still other embodiments, the outer skirt may extend along a substantial portion of the frame. Additional examples of outer skirt features that may be incorporated and/or interchanged with the features described herein are found in U.S. Provisional Application No. 61/789,783 filed Mar. 15, 2013 incorporated by reference herein.
[0052] FIGS. 3 and 4 show additional embodiments of the outer skirt 30′, 30″. In FIG. 3 , the outer skirt 30′ extends along a substantial part of the frame and extends between proximal and distal anchors. The outer skirt 30′ in this embodiment may be one single piece, or may be formed from multiple pieces stitched or otherwise connected together. The tabs 68′ may form sleeves that are configured to surround at least a portion of the proximal anchors to attach the outer skirt to the proximal anchors. As shown in one embodiment, proximal portions of the proximal anchors remain uncovered by the outer skirt 30′. The outer skirt 30′ at the proximal anchors can form an annular ring similar to the second portion 66 of FIG. 2 and can form a substantially cylindrical portion similar to the first portion 64 of FIG. 2 . The distal end of the outer skirt 30′ can attach and/or cover the distal anchors 24. In some embodiments, the distal end of the outer skirt 30′ extends to the distal anchors 24 but does not cover or connect to them. In addition, a valve skirt 70 may also be used which may create some overlap of skirts in some embodiments.
[0053] In FIG. 4 the outer skirt 30″ is shown attached to the distal ends of the proximal anchors 22 with tabs 68″. The outer skirt 30″ then extends proximally to essentially the base of the proximal anchor. From that point, the outer skirt extends distally towards the distal end. Again the outer skirt may or may not attach to the distal anchors. In the illustrated embodiment of FIG. 4 , the outer skirt 30″ wraps around each of the distal anchors.
[0054] Turning now to FIG. 6 , a detail view of an embodiments is shown where the proximal anchors 22 can include eyelets 46 that may be used to secure the skirt to the anchor. In this embodiment, the proximal anchor has an end 26 that instead of extending generally distally, it extends generally radially outwardly, and as illustrated extends in a direction perpendicular or substantially perpendicular to the longitudinal axis of the frame. The tab 68 can be attached to the eyelet 46, for example by stitching. As shown, the eyelet 46 is positioned at the end of the anchor, but it will be understood that it can be spaced proximally from the end. In some embodiments, the proximal anchors can be looped anchors or have a looped end. A small tab can be passed through the looped anchor or looped end and connected to the skirt to form a loop on the skirt. Further, the outer skirt 30 may attach directly to the eyelets 46 without the need for tabs 68.
[0055] In some embodiments, the outer skirt 30 can be part of, or connected to, the valve skirt 70, such as being connected to the valve skirt 70 at or near the distal end 34 of the frame.
[0056] The outer skirt 30 can be constructed in multiple different ways and may be made of similar material to the valve skirt 70. The outer skirt 30 can be made of a layer of resilient material, such as knit polyester or another stretchable or flexible fabric. In some embodiments, the outer skirt 30 is made from a material that is more flexible than the valve leaflet material. The distal and/or proximal end of the outer skirt 30 can be straight, curved, or have any other desired configuration. The outer skirt 30 can be formed of one piece or multiple pieces. For example, the outer skirt 30 attached to the frame 20 can be one piece and then each proximal anchor 22 can be covered by a separate piece of material of the outer skirt 30. It is to be understood that other configurations of the outer skirt 30 can also be employed. For example, the anchors may remain uncovered, or only a portion may be covered.
[0057] The outer skirt 30 can beneficially prevent axial flow of fluid around an exterior of the prosthesis. For example, with the outer skirt 30 be positioned annularly around an exterior of the expandable frame and secured to at least some of the plurality of proximal anchors, the outer skirt creates an axial barrier to fluid flow exterior to the frame when deployed within a body cavity. In addition, the skirt can encourage tissue in-growth between the skirt and the natural tissue. This may further help to prevent leakage of blood flow around the heart valve.
[0058] In one embodiment, the outer skirt 30 can be used to help prevent leakage of blood flow around a heart valve, such as a mitral valve, when the prosthesis is placed in a native heart valve. For example, the outer skirt 30 can engage an atrial side of the mitral valve. The proximal anchors can also engage the mitral valve forcing the outer skirt 30 into close contact with the valve to block flow from passing through the mitral valve from outside of the frame.
[0059] In preferred embodiments, the prostheses 10 in the form of a replacement heart such as described above may be deployed into a heart valve annulus. The prosthesis 10 may be delivered into the mitral valve in a radially compacted or collapsed configuration and positioned when compacted so that the anchor tips 26, 28 of the opposing anchors 22, 24 are disposed on opposite sides of the native annulus 98 as shown in FIGS. 5 and 6 . In FIG. 5 , the valve 60 and skirts are not shown for ease of illustration. As the replacement heart valve 10 is expanded, the opposing anchors expand outward away from the frame are may be drawn closer together due to foreshortening of the frame. The anchors may grasp tissue on opposite sides of the native annulus 98 and securely hold the replacement heart valve 10 in position. As such, the replacement heart valve 10 can be held securely in position without requiring a substantial radial force against the native annulus. Because the anchor tips are preferably atraumatic, the grasping or engaging of tissue by the prosthesis minimizes damage to the native tissue. The prosthesis can be deployed into a heart valve or otherwise deployed in manners similar to those described with respect to a replacement heart valve in U.S. Publication Nos. 2010/0298931 and 2012/0078353 the entireties of each of which are hereby incorporated by reference and made a part of this specification.
[0060] FIGS. 5 and 6 show a schematic representation of the replacement heart valve 10 installed in a human heart 84. The heart is shown in cross-section, and represents typical anatomy, including a left atrium 78 and left ventricle 86. The left atrium 78 and left ventricle 86 communicate with one another through a mitral annulus 98. Also shown schematically is a native anterior mitral leaflet 90 having chordae tendineae 92 that connect a downstream end of the anterior mitral leaflet 90 and to the left ventricle 86. FIG. 6 shows an enlarged view of a slightly different prosthesis implanted at the native mitral annulus.
[0061] In one preferred embodiment, a method is provided of delivering a replacement valve to a native mitral valve and atraumatically securing the replacement valve relative to the native mitral valve annulus 98. The replacement valve can be mounted on a delivery device and delivered to the native mitral valve annulus while the replacement valve is in a radially compacted state. The replacement valve may be positioned so that the ends or tips of the distal anchors are on a ventricular side of the native leaflets 90 beyond a location where chordae tendineae 92 connect to free ends of the native leaflets. At least a portion of the replacement valve can be released from the delivery device to thereby expand the distal anchors radially outwardly. At this time the distal anchors may extend between at least some of the chordae. The distal anchors (along with the frame) can be moved toward the ventricular side of the native valve annulus with the distal anchors extending between at least some of the chordae tendineae to provide tension on the chordae tendineae. With tension provided on the chordae tendineae, the replacement valve can be further released from the delivery device to thereby expand the proximal anchors radially outwardly. The proximal anchors upon further release of the replacement valve from the delivery device can move into engagement with tissue on an atrial side of the native valve annulus, such as with the atrial side of the native valve annulus.
[0062] The method just described may utilize any of the prostheses herein described, including those described in the patent and applications incorporated by reference. The illustrated prosthesis where the ends of the distal anchors are not positioned as far out radially as the ends of the proximal anchors when the frame is expanded can beneficially be used in this method. Thus, the distal anchors may have a suitable length for extending between and providing tension on the chordae tendineae, but need not and may in some embodiments not engage tissue with the tips 28, such as shown in FIG. 6 . Thus, in some embodiments some or all of the distal anchors remain spaced from tissue on the ventricular side of the native valve annulus after delivery and expansion. The interaction between the distal anchors and the chordae tendineae may therefore be sufficient to secure the distal end of the prosthesis, while the engagement of the proximal anchors with tissue on the atrial side of the native valve annulus will help further secure and orient the prosthesis
[0063] As illustrated in FIGS. 5 and 6 , the distal anchors may comprise loops, such as any of the looped structures previously described. The proximal and/or distal anchors may also be covered with a resilient material such as described above for the outer skirt 30 and valve skirt 70 that promotes tissue growth with adjacent body tissue. Such material may also be useful to prevent paravalvular leakage. The atraumatic distal anchors may advantageously prevent snagging of the prosthesis on internal structures, such as the papillary muscles.
[0064] When the prosthesis is in an expanded configuration within the native mitral heart valve, the engagement of the proximal anchors 22 with tissue on the atrial side of the native mitral valve causes at least a portion of the outer skirt 30 to also engage the tissue on the atrial side of the native mitral valve. A portion of the outer skirt extends distally from the proximal anchors toward the ventricle. Because the diameter of the outer skirt decreases to a size of close or the same in dimension as the frame, the outer skirt form a barrier to blood flow around the outside or external to the frame. The outer skirt 30 can be forced against the outside of the frame 20 by the native leaflets. Where the native leaflets do not force the outer skirt 30 against the frame, or where the contact is not as strong, the outer skirt 30 is still present to block, or impede blood flow. It will be understood that having multiple contact points between the native valve and the outer skirt can allow the outer skirt to securely cover areas where there are fewer contacts between the two. As described above, the outer skirt may also promote tissue growth with tissue that it contacts.
[0065] In addition, due to the preferred outer dimension of the anchors relative to the diameter or radius of the frame in some embodiments, when the frame is radially expanded such that the proximal and/or distal anchors engage tissue at or around the native mitral valve annulus, the frame may move reciprocally in an axial direction relative to the native mitral valve annulus in a constrained floating manner. The one or more of the anchors 22, 24 can be made to flex to provide this reciprocal movement; for example, around the bends between the segments 50, 56 and the base of the anchors. The frame does not exert a significant amount of radial force to the native mitral valve annulus or adjacent tissues, and the frame is primarily secured with the anchors. When in use, the frame may then move relative to the anchor ends as the heart is beating.
[0066] The embodiments described in FIGS. 1-6 above may have further advantages. As illustrated in FIG. 1 , some embodiments have only 3 rows of cells or less, which makes the prosthesis longitudinally shorter and therefore easier to navigate when collapsed through tortuous pathways (e.g., percutaneously). Because of the dimensions of the anchors relative to the size of the frame, the frame itself may be made relatively smaller, which also helps facilitate a lower profile for the prosthesis helpful for delivery and implantation. Moreover, having a prosthesis that can “float” within a native annulus may be usable for a wider variety of patient anatomies, as one or a fewer number of radial sizes of the frames can be used to fit a greater number of patients. In such embodiments, because the anchors are configured to extend further from the frame, these prostheses are still able to securely grasp native tissue as the anchors can expand to different diameters depending on how they are constrained with a body cavity. In the context of a replacement heart valve, the frame (and the associated valve body) may have the same size across multiple patient sizes, and the anchors can either be configured to expand to different diameters, or different anchor arrangements may be used for different frames.
[0067] Although this invention has been disclosed in the context of certain preferred embodiments and examples, it will be understood by those skilled in the art that the present invention extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses of the invention and obvious modifications and equivalents thereof. In addition, while a number of variations of the invention have been shown and described in detail, other modifications, which are within the scope of this invention, will be readily apparent to those of skill in the art based upon this disclosure. It is also contemplated that various combinations or sub-combinations of the specific features and aspects of the embodiments may be made and still fall within the scope of the invention. Accordingly, it should be understood that various features and aspects of the disclosed embodiments can be combined with or substituted for one another in order to form varying modes of the disclosed invention. Thus, it is intended that the scope of the present invention herein disclosed should not be limited by the particular disclosed embodiments described above, but should be determined only by a fair reading of the claims that follow.
[0068] Similarly, this method of disclosure, is not to be interpreted as reflecting an intention that any claim require more features than are expressly recited in that claim. Rather, as the following claims reflect, inventive aspects lie in a combination of fewer than all features of any single foregoing disclosed embodiment. Thus, the claims following the Detailed Description are hereby expressly incorporated into this Detailed Description, with each claim standing on its own as a separate embodiment.
Claims
What is claimed is:
1. A prosthesis configured to grasp intralumenal tissue when deployed within a body cavity, the prosthesis comprising:
an expandable frame portion comprising a proximal end and a distal end and a longitudinal axis extending therethrough, the expandable frame portion comprising a plurality of foreshortening cells configured to collapse radially for delivery and to expand radially upon deployment, the expandable frame portion being configured to longitudinally foreshorten upon radial expansion;
a plurality of proximal anchors extending from the expandable frame portion and expandable from a collapsed configuration to an expanded configuration, wherein in the expanded configuration, each proximal anchor extends proximally away from the proximal end of the expandable frame portion and then turns to extend radially outwardly from the expandable frame portion;
a plurality of distal anchors extending from the expandable frame portion and expandable from a collapsed configuration to an expanded configuration, wherein in the expanded configuration, each distal anchor extends distally away from the distal end of the expandable frame portion and then turns to extend proximally, each distal anchor extending to an end positioned radially outward from the expandable frame portion; and
a skirt comprising:
a distal portion extending along an exterior of the expandable frame portion and the distal anchors; and
a proximal portion sized to extend along at least a portion of the plurality of proximal anchors, wherein an end of the proximal portion is positioned further radially outward from the longitudinal axis than the ends of the distal anchors wherein the entirety of the proximal portion of the skirt is spaced distally from the proximal end of the expandable frame portion;
wherein the proximal anchors and distal anchors are separated by the plurality of foreshortening cells such that the proximal anchors and distal anchors are configured to be drawn closer together along the longitudinal axis when the expandable frame portion foreshortens; and
wherein each distal anchor extends distally from the expandable frame portion along a first segment, the first segment being substantially parallel with the longitudinal axis.
2. The prosthesis of claim 1, wherein at least some of the proximal anchors and/or distal anchors comprise looped ends.
3. The prosthesis of claim 1, wherein all of the plurality of proximal anchors and the plurality of distal anchors comprise looped ends.
4. The prosthesis of claim 2, wherein at least some of the anchors comprising looped ends are connected to the expandable frame portion at a first base and a second base spaced apart from each other.
5. The prosthesis of claim 2, wherein at least some of the anchors comprising looped ends are connected to the expandable frame portion by a single strut.
6. The prosthesis of claim 1, wherein the expandable frame portion, the plurality of proximal anchors and the plurality of distal anchors are formed from a single piece of material.
7. The prosthesis of claim 1, wherein the ends of at least some of the proximal anchors and/or distal anchors are substantially parallel with the longitudinal axis when the expandable frame portion is at least partially expanded and the proximal and distal anchors are in their expanded configurations.
8. The prosthesis of claim 1, wherein the ends of at least some of the proximal anchors are substantially perpendicular with the longitudinal axis when the expandable frame portion is at least partially expanded and the proximal anchors are in their expanded configurations.
9. A replacement mitral valve comprising the prosthesis of claim 1, wherein when the expandable frame portion is in an expanded configuration, the expandable frame portion is positionable within a native mitral valve annulus such that:
the distal anchors are positionable within the ventricle and have portions that extend generally proximally toward a ventricular side of the native mitral valve annulus.
10. The replacement mitral valve of claim 9, wherein the distal anchors are positionable within the ventricle and extend proximally to ends spaced distally from the native mitral valve annulus.
11. The replacement mitral valve of claim 9, wherein the distal anchors are positionable within the ventricle and extend proximally to ends that engage the native mitral valve annulus.
12. The replacement mitral valve of claim 9, wherein the proximal anchors atraumatically engage tissue on an atrial side of the native mitral valve annulus.
13. The prosthesis of claim 1, wherein each proximal anchor turns to extends distally after extending proximally from the proximal end of the expandable frame portion.
14. The prosthesis of claim 1, wherein each proximal anchor comprises a cell which extends proximally away from the proximal end of the expandable frame portion and then turns to extend radially outwardly from the expandable frame portion.
15. The prosthesis of claim 1, wherein in the expanded configuration, each of the plurality of distal anchors is bent to extend radially outwardly away from the first segment along a second segment and is then bent to extend proximally along a third segment.
16. The prosthesis of claim 1, wherein adjacent proximal anchors extend from a same corner of a foreshortening cell.
17. The prosthesis of claim 1, wherein the expandable frame portion comprises a first row of foreshortening cells and a second row of foreshortening cells, wherein the one or more foreshortening cells of the first row comprise a shape which is different from a shape of one or more of the foreshortening cells of the second row.
18. The prosthesis of claim 1, wherein the proximal anchors are each connected to the expandable frame portion at a first base and a second base spaced apart from each other and wherein a longitudinal strut extends between at least one of the proximal anchors.
19. The prosthesis of claim 1, wherein the plurality of distal anchors are approximately equally spaced around a periphery of the expandable frame portion.
20. A prosthesis configured to grasp intralumenal tissue when deployed within a native mitral valve, the prosthesis comprising:
an expandable frame portion comprising a proximal end and a distal end and a longitudinal axis extending therethrough, the expandable frame portion comprising a plurality of foreshortening cells configured to collapse radially for delivery and to expand radially upon deployment;
a proximal anchoring portion extending from the expandable frame portion and expandable from a collapsed configuration to an expanded configuration, wherein when the proximal anchoring portion is in an expanded configuration:
at least a portion of the proximal anchoring portion extends proximally; and
at least a portion of the proximal anchoring portion extends radially outwardly in a direction generally perpendicular to the longitudinal axis, the portion of the proximal anchoring portion that extends radially outwardly being sized and shaped to contact an atrial side of a native valve annulus;
a distal anchoring portion extending from the expandable frame portion and expandable from a collapsed configuration to an expanded configuration, the distal anchoring portion comprising a plurality of distal anchors which are each connected to the expandable frame portion at a first base and a second base spaced apart from each other, wherein when the distal anchoring portion is in an expanded configuration:
at least a portion of each distal anchor extends radially outward from the expandable frame portion; and
at least one distal anchor comprises at least one bend, the end of the at least one distal anchor extending toward the proximal end of the expandable frame portion; and
a skirt annularly positioned around an exterior of the expandable frame portion to create an axial barrier to fluid flow exterior to the expandable frame portion when deployed within the body cavity, the skirt comprising:
a first portion sized and shaped to extend along and follow the shape of the exterior of expandable frame portion when the expandable frame portion is in an expanded configuration, the first portion having a proximal end and a distal end,
a second portion configured to be positioned radially between the expandable frame portion and the distal anchoring portion when the expandable frame portion is in an expanded configuration, the second portion extending from the distal end of the first portion and extending at least along an inwardly facing surface of the distal anchoring portion; and
a third portion extending radially outward from the expandable frame portion when the expandable frame portion is in an expanded configuration, the third portion extending radially outward from a location spaced from the proximal end of the expandable frame portion, the third portion extending from the proximal end of the first portion and extending along at least a portion of the plurality of proximal anchors, wherein an end of the third portion is positioned further radially outward from the longitudinal axis than the ends of the distal anchors; and
a plurality of locking tabs extending proximally, wherein when the expandable frame portion is in an expanded configuration the plurality of locking tabs extend proximally of the expandable frame portion and the proximal anchoring portion.
21. The prosthesis of claim 20, wherein the expandable frame portion is configured to longitudinally foreshorten upon radial expansion and wherein the proximal anchoring portion and at least the plurality of anchors of the distal anchoring portion are separated by the plurality of foreshortening cells such that the proximal anchoring portion and at least the plurality of anchors of the distal anchoring portion are configured to be drawn closer together along the longitudinal axis when the expandable frame portion foreshortens.
22. The prosthesis of claim 20, wherein the third portion of the skirt extends in a direction generally perpendicular to the longitudinal axis.
23. The prosthesis of claim 20, wherein the third portion of the skirt forms an annular ring.
24. The prosthesis of claim 20, wherein the entirety of the third portion of the skirt is positioned distal of proximal ends of the foreshortening cells.
25. A prosthesis configured to grasp intralumenal tissue when deployed within a native mitral valve, the prosthesis comprising:
an expandable frame portion comprising a proximal end and a distal end and a longitudinal axis extending therethrough, the expandable frame portion comprising a proximal row of foreshortening cells and a distal row of foreshortening cells, the foreshortening cells configured to collapse radially for delivery and to expand radially upon deployment, the expandable frame portion being configured to longitudinally foreshorten upon radial expansion;
a plurality of proximal anchors extending from the expandable frame portion and expandable from a collapsed configuration to an expanded configuration, each of the proximal anchors extending from junctions between the proximal row of foreshortening cells, wherein in an expanded configuration, ends of the plurality of proximal anchors are positioned radially outwardly relative from the expandable frame portion and extend in a direction substantially perpendicular to the longitudinal axis, the ends being axially positioned distal of the proximal end of the expandable frame portion;
a plurality of distal anchors extending from the expandable frame portion and expandable from a collapsed configuration to an expanded configuration, each of the distal anchors connected to a base at a distal portion of the distal row of foreshortening cells, wherein in an expanded configuration, ends of the plurality of distal anchors are positioned radially outwardly relative from the expandable frame portion and the axial length between the base and the ends is less than a length of the cells of the distal row when in an expanded configuration; and
a skirt annularly positioned around an exterior of the expandable frame portion to create an axial barrier to fluid flow exterior to the expandable frame portion when deployed within the body cavity, the skirt comprising:
a generally cylindrical portion having a proximal end and a distal end; and
a ring-shaped portion extending radially outward from the frame at a location axially spaced from the proximal end to prevent axial flow of fluid around an exterior of the prosthesis, the ring-shaped portion comprising an inner edge extending from the proximal end of generally cylindrical portion of the skirt, the ring-shaped portion extending radially outwardly from the inner edge to an outer edge;
wherein the proximal anchors and distal anchors are configured to be drawn closer together along the longitudinal axis when the expandable frame portion foreshortens.
26. The prosthesis of claim 25, wherein the expandable frame portion comprises a plurality of longitudinally extending struts, wherein one or more of the longitudinally extending struts extends distally from an apex of a foreshortening cell and comprises at least one eyelet extending through the longitudinally extending strut for attaching a valve to the expandable frame.
Patent Citations (768)
| Patent | Date | Inventor | Cited By |
|---|---|---|---|
| US865203(A) | 1907-09-01 | Mustonen et al. | Applicant |
| US1306391(A) | 1919-06-01 | Romanoff | Applicant |
| US3312237(A) | 1967-04-01 | Mon et al. | Applicant |
| US3657744(A) | 1972-04-01 | Ersek | Applicant |
| US3671979(A) | 1972-06-01 | Moulopoulos | Applicant |
| US3739402(A) | 1973-06-01 | Cooley et al. | Applicant |
| US4056854(A) | 1977-11-01 | Boretos et al. | Applicant |
| US4079468(A) | 1978-03-01 | Liotta et al. | Applicant |
| US4204283(A) | 1980-05-01 | Bellhouse et al. | Applicant |
| US4222126(A) | 1980-09-01 | Boretos et al. | Applicant |
| US4265694(A) | 1981-05-01 | Boretos et al. | Applicant |
| US4339831(A) | 1982-07-01 | Johnson | Applicant |
| US4340977(A) | 1982-07-01 | Brownlee et al. | Applicant |
| US4470157(A) | 1984-09-01 | Love | Applicant |
| US4477930(A) | 1984-10-01 | Totten et al. | Applicant |
| US4490859(A) | 1985-01-01 | Black et al. | Applicant |
| US4553545(A) | 1985-11-01 | Maass et al. | Applicant |
| US4655771(A) | 1987-04-01 | Wallsten | Applicant |
| US4733665(A) | 1988-03-01 | Palmaz | Applicant |
| US4776337(A) | 1988-10-01 | Palmaz | Applicant |
| US4777951(A) | 1988-10-01 | Cribier et al. | Applicant |
| US4865600(A) | 1989-09-01 | Carpentier et al. | Applicant |
| US4908028(A) | 1990-03-01 | Colon et al. | Applicant |
| US4950227(A) | 1990-08-01 | Savin et al. | Applicant |
| US4994077(A) | 1991-02-01 | Dobben | Applicant |
| US5049154(A) | 1991-09-01 | Quadri | Applicant |
| US5133725(A) | 1992-07-01 | Quadri | Applicant |
| US5197978(A) | 1993-03-01 | Hess | Applicant |
| US5282826(A) | 1994-02-01 | Quadri | Applicant |
| US5326371(A) | 1994-07-01 | Love et al. | Applicant |
| US5332402(A) | 1994-07-01 | Teitelbaum | Applicant |
| US5344427(A) | 1994-09-01 | Cottenceau et al. | Applicant |
| US5370685(A) | 1994-12-01 | Stevens | Applicant |
| US5397355(A) | 1995-03-01 | Marin | Applicant |
| US5411552(A) | 1995-05-01 | Andersen et al. | Applicant |
| US5415667(A) | 1995-05-01 | Frater | Applicant |
| US5439446(A) | 1995-08-01 | Barry | Applicant |
| US5449385(A) | 1995-09-01 | Religa et al. | Applicant |
| US5474563(A) | 1995-12-01 | Myler et al. | Applicant |
| US5509930(A) | 1996-04-01 | Love | Applicant |
| US5545214(A) | 1996-08-01 | Stevens | Applicant |
| US5554185(A) | 1996-09-01 | Block et al. | Applicant |
| US5575818(A) | 1996-11-01 | Pinchuk | Applicant |
| US5607444(A) | 1997-03-01 | Lam | Applicant |
| US5607469(A) | 1997-03-01 | Frey | Applicant |
| US5669919(A) | 1997-09-01 | Sanders et al. | Applicant |
| US5697382(A) | 1997-12-01 | Love et al. | Applicant |
| USD390957(S) | 1998-02-01 | Fontaine | Applicant |
| US5713952(A) | 1998-02-01 | Vanney et al. | Applicant |
| US5725519(A) | 1998-03-01 | Penner | Applicant |
| US5769812(A) | 1998-06-01 | Stevens et al. | Applicant |
| US5807398(A) | 1998-09-01 | Shaknovich | Applicant |
| US5810873(A) | 1998-09-01 | Morales | Applicant |
| US5840081(A) | 1998-11-01 | Andersen et al. | Applicant |
| US5855601(A) | 1999-01-01 | Bessler et al. | Applicant |
| US5868777(A) | 1999-02-01 | Lam | Applicant |
| US5868782(A) | 1999-02-01 | Frantzen | Applicant |
| US5876437(A) | 1999-03-01 | Vanney et al. | Applicant |
| US5879381(A) | 1999-03-01 | Moriuch et al. | Applicant |
| US5902334(A) | 1999-05-01 | Dwyer et al. | Applicant |
| US5935108(A) | 1999-08-01 | Katoh | Applicant |
| US5954764(A) | 1999-09-01 | Parodi | Applicant |
| US5957949(A) | 1999-09-01 | Leonhardt et al. | Applicant |
| US5992000(A) | 1999-11-01 | Humphrey et al. | Applicant |
| US6004328(A) | 1999-12-01 | Solar | Applicant |
| US6015431(A) | 2000-01-01 | Thornton et al. | Applicant |
| US6042606(A) | 2000-03-01 | Frantzen | Applicant |
| US6053940(A) | 2000-04-01 | Wijay | Applicant |
| US6086612(A) | 2000-07-01 | Jansen | Applicant |
| US6113612(A) | 2000-09-01 | Swanson et al. | Applicant |
| US6113631(A) | 2000-09-01 | Jansen | Applicant |
| US6132458(A) | 2000-10-01 | Staehle et al. | Applicant |
| US6152937(A) | 2000-11-01 | Peterson et al. | Applicant |
| US6159237(A) | 2000-12-01 | Alt | Applicant |
| US6168614(B1) | 2001-01-01 | Andersen et al. | Applicant |
| US6168616(B1) | 2001-01-01 | Brown, III | Applicant |
| US6251093(B1) | 2001-06-01 | Valley et al. | Applicant |
| US6280466(B1) | 2001-08-01 | Kugler et al. | Applicant |
| US6306141(B1) | 2001-10-01 | Jervis | Applicant |
| US6309416(B1) | 2001-10-01 | Swanson et al. | Applicant |
| US6312465(B1) | 2001-11-01 | Griffin et al. | Applicant |
| US6336938(B1) | 2002-01-01 | Kavteladze et al. | Applicant |
| US6352543(B1) | 2002-03-01 | Cole | Applicant |
| US6358277(B1) | 2002-03-01 | Duran | Applicant |
| US6409759(B1) | 2002-06-01 | Peredo | Applicant |
| US6425916(B1) | 2002-07-01 | Garrison et al. | Applicant |
| US6440163(B1) | 2002-08-01 | Swanson et al. | Applicant |
| US6440164(B1) | 2002-08-01 | DeMatteo et al. | Applicant |
| US6454799(B1) | 2002-09-01 | Schreck | Applicant |
| US6458153(B1) | 2002-10-01 | Bailey et al. | Applicant |
| US6475237(B2) | 2002-11-01 | Drasler et al. | Applicant |
| US6482228(B1) | 2002-11-01 | Norred | Applicant |
| US6511491(B2) | 2003-01-01 | Grudem et al. | Applicant |
| US6517573(B1) | 2003-02-01 | Pollock | Applicant |
| US6527800(B1) | 2003-03-01 | McGuckin, Jr. et al. | Applicant |
| US6533812(B2) | 2003-03-01 | Swanson et al. | Applicant |
| US6551303(B1) | 2003-04-01 | Van Tassei et al. | Applicant |
| US6582462(B1) | 2003-06-01 | Andersen et al. | Applicant |
| US6602281(B1) | 2003-08-01 | Klein | Applicant |
| US6610088(B1) | 2003-08-01 | Gabbay | Applicant |
| US6641606(B2) | 2003-11-01 | Ouriel et al. | Applicant |
| US6652578(B2) | 2003-11-01 | Bailey et al. | Applicant |
| USD484979(S) | 2004-01-01 | Fontaine | Applicant |
| US6676698(B2) | 2004-01-01 | McGuckin et al. | Applicant |
| US6682537(B2) | 2004-01-01 | Ouriel et al. | Applicant |
| US6695878(B2) | 2004-02-01 | McGuckin et al. | Applicant |
| US6712836(B1) | 2004-03-01 | Berg et al. | Applicant |
| US6723123(B1) | 2004-04-01 | Kazatchkov et al. | Applicant |
| US6730118(B2) | 2004-05-01 | Spenser et al. | Applicant |
| US6733523(B2) | 2004-05-01 | Shaolian et al. | Applicant |
| US6764505(B1) | 2004-07-01 | Hossainy et al. | Applicant |
| US6767362(B2) | 2004-07-01 | Schreck | Applicant |
| US6780200(B2) | 2004-08-01 | Jansen | Applicant |
| US6790229(B1) | 2004-09-01 | Berreklouw | Applicant |
| US6790230(B2) | 2004-09-01 | Beyersdorf et al. | Applicant |
| US6814746(B2) | 2004-11-01 | Thompson et al. | Applicant |
| US6830584(B1) | 2004-12-01 | Sequin | Applicant |
| US6858034(B1) | 2005-02-01 | Hijlkema et al. | Applicant |
| US6875231(B2) | 2005-04-01 | Anduiza et al. | Applicant |
| US6893460(B2) | 2005-05-01 | Spenser et al. | Applicant |
| US6908477(B2) | 2005-06-01 | McGuckin, Jr. et al. | Applicant |
| US6908481(B2) | 2005-06-01 | Cribier | Applicant |
| US6926732(B2) | 2005-08-01 | Derus et al. | Applicant |
| US6929660(B1) | 2005-08-01 | Ainsworth et al. | Applicant |
| US6936058(B2) | 2005-08-01 | Forde et al. | Applicant |
| US6960219(B2) | 2005-11-01 | Grudem et al. | Applicant |
| US6979350(B2) | 2005-12-01 | Moll et al. | Applicant |
| US7014653(B2) | 2006-03-01 | Ouriel et al. | Applicant |
| US7018401(B1) | 2006-03-01 | Hyodoh et al. | Applicant |
| US7018406(B2) | 2006-03-01 | Seguin et al. | Applicant |
| US7025780(B2) | 2006-04-01 | Gabbay | Applicant |
| US7044134(B2) | 2006-05-01 | Khairkhahan et al. | Applicant |
| US7044962(B2) | 2006-05-01 | Elliott | Applicant |
| US7044966(B2) | 2006-05-01 | Svanidze et al. | Applicant |
| US7087088(B2) | 2006-08-01 | Berg et al. | Applicant |
| US7147660(B2) | 2006-12-01 | Chobotov et al. | Applicant |
| US7147661(B2) | 2006-12-01 | Chobotov et al. | Applicant |
| US7153322(B2) | 2006-12-01 | Alt | Applicant |
| US7186265(B2) | 2007-03-01 | Sharkawy et al. | Applicant |
| US7198646(B2) | 2007-04-01 | Figulla et al. | Applicant |
| US7201772(B2) | 2007-04-01 | Schwammenthal et al. | Applicant |
| US7232449(B2) | 2007-06-01 | Sharkawy et al. | Applicant |
| US7252682(B2) | 2007-08-01 | Seguin | Applicant |
| USD553747(S) | 2007-10-01 | Fliedner | Applicant |
| US7276078(B2) | 2007-10-01 | Spenser et al. | Applicant |
| US7276084(B2) | 2007-10-01 | Yang et al. | Applicant |
| US7328270(B1) | 2008-02-01 | Reents et al. | Applicant |
| US7329278(B2) | 2008-02-01 | Seguin et al. | Applicant |
| US7374571(B2) | 2008-05-01 | Pease et al. | Applicant |
| US7381219(B2) | 2008-06-01 | Salahieh et al. | Applicant |
| US7393360(B2) | 2008-07-01 | Spenser et al. | Applicant |
| US7422602(B2) | 2008-09-01 | Grudem et al. | Applicant |
| US7425219(B2) | 2008-09-01 | Quadri | Applicant |
| US7429269(B2) | 2008-09-01 | Schwammenthal et al. | Applicant |
| US7442204(B2) | 2008-10-01 | Schwammenthal et al. | Applicant |
| US7445631(B2) | 2008-11-01 | Salahieh et al. | Applicant |
| US7462191(B2) | 2008-12-01 | Spenser et al. | Applicant |
| US7510575(B2) | 2009-03-01 | Spenser et al. | Applicant |
| US7524330(B2) | 2009-04-01 | Berreklouw | Applicant |
| US7534261(B2) | 2009-05-01 | Friedman | Applicant |
| US7585321(B2) | 2009-09-01 | Cribier | Applicant |
| US7608114(B2) | 2009-10-01 | Levine et al. | Applicant |
| US7615072(B2) | 2009-11-01 | Rust et al. | Applicant |
| US7618446(B2) | 2009-11-01 | Andersen et al. | Applicant |
| US7628805(B2) | 2009-12-01 | Spenser et al. | Applicant |
| US7632298(B2) | 2009-12-01 | Hijlkema et al. | Applicant |
| US7748389(B2) | 2010-07-01 | Salahieh et al. | Applicant |
| US7753949(B2) | 2010-07-01 | Lamphere et al. | Applicant |
| USD622387(S) | 2010-08-01 | Igaki | Applicant |
| USD622388(S) | 2010-08-01 | Igaki | Applicant |
| US7771463(B2) | 2010-08-01 | Ton et al. | Applicant |
| US7771472(B2) | 2010-08-01 | Hedricksen et al. | Applicant |
| US7785360(B2) | 2010-08-01 | Freitag | Applicant |
| US7803185(B2) | 2010-09-01 | Gabbay | Applicant |
| US7806917(B2) | 2010-10-01 | Xiao | Applicant |
| US7806919(B2) | 2010-10-01 | Bloom et al. | Applicant |
| US7815589(B2) | 2010-10-01 | Meade et al. | Applicant |
| US7815673(B2) | 2010-10-01 | Bloom et al. | Applicant |
| US7824443(B2) | 2010-11-01 | Salahieh et al. | Applicant |
| US7846203(B2) | 2010-12-01 | Cribier | Applicant |
| US7871435(B2) | 2011-01-01 | Carpentier | Applicant |
| US7892281(B2) | 2011-02-01 | Seguin et al. | Applicant |
| USD635261(S) | 2011-03-01 | Rossi | Applicant |
| USD635262(S) | 2011-03-01 | Rossi | Applicant |
| US7914569(B2) | 2011-03-01 | Nguyen et al. | Applicant |
| US7947075(B2) | 2011-05-01 | Goetz et al. | Applicant |
| US7959672(B2) | 2011-06-01 | Salahieh et al. | Applicant |
| US7972377(B2) | 2011-07-01 | Lane | Applicant |
| US7972378(B2) | 2011-07-01 | Tabor et al. | Applicant |
| US7981151(B2) | 2011-07-01 | Rowe | Applicant |
| US7993392(B2) | 2011-08-01 | Righini et al. | Applicant |
| US7993394(B2) | 2011-08-01 | Hariton et al. | Applicant |
| US8016870(B2) | 2011-09-01 | Chew et al. | Applicant |
| US8016877(B2) | 2011-09-01 | Seguin et al. | Applicant |
| US8048153(B2) | 2011-11-01 | Salahieh et al. | Applicant |
| US8052750(B2) | 2011-11-01 | Tuval et al. | Applicant |
| US8070800(B2) | 2011-12-01 | Lock et al. | Applicant |
| US8070802(B2) | 2011-12-01 | Lamphere et al. | Applicant |
| US8075615(B2) | 2011-12-01 | Eberhardt et al. | Applicant |
| US8080054(B2) | 2011-12-01 | Rowe | Applicant |
| US8092520(B2) | 2012-01-01 | Quadri | Applicant |
| US8109996(B2) | 2012-02-01 | Stacchino | Applicant |
| US8136218(B2) | 2012-03-01 | Millwee et al. | Applicant |
| US8137398(B2) | 2012-03-01 | Tuval et al. | Applicant |
| US8157852(B2) | 2012-04-01 | Bloom et al. | Applicant |
| US8167926(B2) | 2012-05-01 | Hartley et al. | Applicant |
| US8167932(B2) | 2012-05-01 | Bourang et al. | Applicant |
| US8167934(B2) | 2012-05-01 | Styrc et al. | Applicant |
| US8177799(B2) | 2012-05-01 | Orban, III | Applicant |
| US8182528(B2) | 2012-05-01 | Salahieh et al. | Applicant |
| US8182530(B2) | 2012-05-01 | Huber | Applicant |
| US8216261(B2) | 2012-07-01 | Solem | Applicant |
| US8216301(B2) | 2012-07-01 | Bonhoeffer et al. | Applicant |
| US8219229(B2) | 2012-07-01 | Cao et al. | Applicant |
| US8220121(B2) | 2012-07-01 | Hendriksen et al. | Applicant |
| US8221482(B2) | 2012-07-01 | Cottone et al. | Applicant |
| US8221493(B2) | 2012-07-01 | Boyle et al. | Applicant |
| US8226710(B2) | 2012-07-01 | Nguyen et al. | Applicant |
| USD665079(S) | 2012-08-01 | Zago | Applicant |
| USD665080(S) | 2012-08-01 | Zago | Applicant |
| US8236045(B2) | 2012-08-01 | Benichou et al. | Applicant |
| US8246675(B2) | 2012-08-01 | Zegdi | Applicant |
| US8246678(B2) | 2012-08-01 | Salahieh et al. | Applicant |
| US8252051(B2) | 2012-08-01 | Chau et al. | Applicant |
| US8252052(B2) | 2012-08-01 | Salahieh et al. | Applicant |
| US8287584(B2) | 2012-10-01 | Salahieh et al. | Applicant |
| US8303653(B2) | 2012-11-01 | Bonhoeffer et al. | Applicant |
| US8313525(B2) | 2012-11-01 | Tuval et al. | Applicant |
| US8317854(B1) | 2012-11-01 | Ryan et al. | Applicant |
| US8323335(B2) | 2012-12-01 | Rowe et al. | Applicant |
| US8337541(B2) | 2012-12-01 | Quadri et al. | Applicant |
| US8353953(B2) | 2013-01-01 | Giannetti et al. | Applicant |
| US8361137(B2) | 2013-01-01 | Perouse | Applicant |
| US8361537(B2) | 2013-01-01 | Shanley | Applicant |
| US8398708(B2) | 2013-03-01 | Meiri et al. | Applicant |
| US8403983(B2) | 2013-03-01 | Quadri et al. | Applicant |
| US8408214(B2) | 2013-04-01 | Spenser | Applicant |
| US8414644(B2) | 2013-04-01 | Quadri et al. | Applicant |
| US8414645(B2) | 2013-04-01 | Dwork et al. | Applicant |
| US8444689(B2) | 2013-05-01 | Zhang | Applicant |
| US8449466(B2) | 2013-05-01 | Duhay et al. | Applicant |
| US8449599(B2) | 2013-05-01 | Chau et al. | Applicant |
| US8449625(B2) | 2013-05-01 | Campbell et al. | Applicant |
| US8454685(B2) | 2013-06-01 | Hariton et al. | Applicant |
| US8470023(B2) | 2013-06-01 | Eidenschink et al. | Applicant |
| US8470024(B2) | 2013-06-01 | Ghione et al. | Applicant |
| US8475521(B2) | 2013-07-01 | Suri et al. | Applicant |
| US8475523(B2) | 2013-07-01 | Duffy | Applicant |
| US8479380(B2) | 2013-07-01 | Malewicz et al. | Applicant |
| US8491650(B2) | 2013-07-01 | Wiemeyer et al. | Applicant |
| US8500798(B2) | 2013-08-01 | Rowe et al. | Applicant |
| US8511244(B2) | 2013-08-01 | Holecek et al. | Applicant |
| US8512401(B2) | 2013-08-01 | Murray, III et al. | Applicant |
| US8518106(B2) | 2013-08-01 | Duffy et al. | Applicant |
| US8535368(B2) | 2013-09-01 | Headley, Jr. et al. | Applicant |
| US8562663(B2) | 2013-10-01 | Mearns et al. | Applicant |
| US8579964(B2) | 2013-11-01 | Lane et al. | Applicant |
| US8579965(B2) | 2013-11-01 | Bonhoeffer et al. | Applicant |
| US8584849(B2) | 2013-11-01 | McCaffrey | Applicant |
| US8585749(B2) | 2013-11-01 | Shelso | Applicant |
| US8585755(B2) | 2013-11-01 | Chau et al. | Applicant |
| US8585756(B2) | 2013-11-01 | Bonhoeffer et al. | Applicant |
| US8591570(B2) | 2013-11-01 | Revuelta et al. | Applicant |
| US8597348(B2) | 2013-12-01 | Rowe et al. | Applicant |
| US8617236(B2) | 2013-12-01 | Paul et al. | Applicant |
| US8623075(B2) | 2014-01-01 | Murray, III et al. | Applicant |
| US8640521(B2) | 2014-02-01 | Righini et al. | Applicant |
| US8647381(B2) | 2014-02-01 | Essinger et al. | Applicant |
| US8652145(B2) | 2014-02-01 | Maimon et al. | Applicant |
| US8652201(B2) | 2014-02-01 | Oberti et al. | Applicant |
| US8652202(B2) | 2014-02-01 | Alon et al. | Applicant |
| US8652203(B2) | 2014-02-01 | Quadri et al. | Applicant |
| US8668730(B2) | 2014-03-01 | McGuckin, Jr. et al. | Applicant |
| US8668733(B2) | 2014-03-01 | Haug et al. | Applicant |
| US8672992(B2) | 2014-03-01 | Orr | Applicant |
| US8673000(B2) | 2014-03-01 | Tabor et al. | Applicant |
| US8679174(B2) | 2014-03-01 | Ottma et al. | Applicant |
| US8679404(B2) | 2014-03-01 | Liburd et al. | Applicant |
| US8685086(B2) | 2014-04-01 | Navia et al. | Applicant |
| US8707957(B2) | 2014-04-01 | Callister et al. | Applicant |
| US8721707(B2) | 2014-05-01 | Boucher et al. | Applicant |
| US8721708(B2) | 2014-05-01 | Sequin et al. | Applicant |
| US8721714(B2) | 2014-05-01 | Kelley | Applicant |
| US8728154(B2) | 2014-05-01 | Alkhatib | Applicant |
| US8728155(B2) | 2014-05-01 | Montorfano et al. | Applicant |
| US8740974(B2) | 2014-06-01 | Lambrecht et al. | Applicant |
| US8740976(B2) | 2014-06-01 | Tran et al. | Applicant |
| US8747458(B2) | 2014-06-01 | Tuval et al. | Applicant |
| US8747459(B2) | 2014-06-01 | Nguyen et al. | Applicant |
| US8747460(B2) | 2014-06-01 | Tuval et al. | Applicant |
| US8753384(B2) | 2014-06-01 | Leanna | Applicant |
| US8758432(B2) | 2014-06-01 | Solem | Applicant |
| US8764814(B2) | 2014-07-01 | Solem | Applicant |
| US8764818(B2) | 2014-07-01 | Gregg | Applicant |
| US8771344(B2) | 2014-07-01 | Tran et al. | Applicant |
| US8771345(B2) | 2014-07-01 | Tuval et al. | Applicant |
| US8771346(B2) | 2014-07-01 | Tuval et al. | Applicant |
| US8777975(B2) | 2014-07-01 | Kashkarov et al. | Applicant |
| US8778020(B2) | 2014-07-01 | Gregg et al. | Applicant |
| US8784478(B2) | 2014-07-01 | Tuval et al. | Applicant |
| US8784481(B2) | 2014-07-01 | Alkhatib et al. | Applicant |
| US8790387(B2) | 2014-07-01 | Nguyen et al. | Applicant |
| US8795356(B2) | 2014-08-01 | Quadri et al. | Applicant |
| US8795357(B2) | 2014-08-01 | Yohanan et al. | Applicant |
| US8828078(B2) | 2014-09-01 | Salahieh et al. | Applicant |
| US8828079(B2) | 2014-09-01 | Thielen et al. | Applicant |
| US8834564(B2) | 2014-09-01 | Tuval et al. | Applicant |
| US8845718(B2) | 2014-09-01 | Tuval et al. | Applicant |
| US8852267(B2) | 2014-10-01 | Cattaneo | Applicant |
| US8870947(B2) | 2014-10-01 | Shaw | Applicant |
| US8870948(B1) | 2014-10-01 | Erzberger et al. | Applicant |
| US8876883(B2) | 2014-11-01 | Rust | Applicant |
| US8876893(B2) | 2014-11-01 | Dwork et al. | Applicant |
| US8876895(B2) | 2014-11-01 | Tuval et al. | Applicant |
| US8894702(B2) | 2014-11-01 | Quadri et al. | Applicant |
| US8911455(B2) | 2014-12-01 | Quadri et al. | Applicant |
| US8926693(B2) | 2015-01-01 | Duffy et al. | Applicant |
| US8926694(B2) | 2015-01-01 | Costello | Applicant |
| US8945209(B2) | 2015-02-01 | Bonyuet et al. | Applicant |
| US8951299(B2) | 2015-02-01 | Paul et al. | Applicant |
| US8961583(B2) | 2015-02-01 | Hojeibane et al. | Applicant |
| US8961593(B2) | 2015-02-01 | Bonhoeffer et al. | Applicant |
| US8961595(B2) | 2015-02-01 | Alkhatib | Applicant |
| US8974524(B2) | 2015-03-01 | Yeung et al. | Applicant |
| US8979922(B2) | 2015-03-01 | Jayasinghe et al. | Applicant |
| US8986375(B2) | 2015-03-01 | Garde et al. | Applicant |
| US8992608(B2) | 2015-03-01 | Haug et al. | Applicant |
| US8998979(B2) | 2015-04-01 | Seguin et al. | Applicant |
| US8998980(B2) | 2015-04-01 | Shipley et al. | Applicant |
| US9005270(B2) | 2015-04-01 | Perkins et al. | Applicant |
| US9005273(B2) | 2015-04-01 | Salahieh et al. | Applicant |
| US9011521(B2) | 2015-04-01 | Haug et al. | Applicant |
| US9011523(B2) | 2015-04-01 | Seguin | Applicant |
| US9011524(B2) | 2015-04-01 | Eberhardt | Applicant |
| US9023100(B2) | 2015-05-01 | Quadri et al. | Applicant |
| US9028545(B2) | 2015-05-01 | Taylor | Applicant |
| US9029418(B2) | 2015-05-01 | Dove et al. | Applicant |
| US9034032(B2) | 2015-05-01 | McLean et al. | Applicant |
| US9034033(B2) | 2015-05-01 | McLean et al. | Applicant |
| US9039757(B2) | 2015-05-01 | McLean et al. | Applicant |
| US9055937(B2) | 2015-06-01 | Rowe et al. | Applicant |
| US9078749(B2) | 2015-07-01 | Lutter et al. | Applicant |
| US9078751(B2) | 2015-07-01 | Naor | Applicant |
| US9125738(B2) | 2015-09-01 | Figulla et al. | Applicant |
| US9138312(B2) | 2015-09-01 | Tuval et al. | Applicant |
| US9161834(B2) | 2015-10-01 | Taylor et al. | Applicant |
| US2001/0007956(A1) | 2001-07-01 | Letac et al. | Applicant |
| US2001/0021872(A1) | 2001-09-01 | Bailey et al. | Applicant |
| US2001/0047180(A1) | 2001-11-01 | Grudem et al. | Applicant |
| US2001/0047200(A1) | 2001-11-01 | White | Applicant |
| US2002/0016623(A1) | 2002-02-01 | Kula et al. | Applicant |
| US2002/0022853(A1) | 2002-02-01 | Swanson et al. | Applicant |
| US2002/0032481(A1) | 2002-03-01 | Gabbay | Applicant |
| US2002/0045929(A1) | 2002-04-01 | Diaz | Applicant |
| US2002/0052644(A1) | 2002-05-01 | Shaolian et al. | Applicant |
| US2002/0055772(A1) | 2002-05-01 | McGuckin et al. | Applicant |
| US2002/0077695(A1) | 2002-06-01 | Swanson et al. | Applicant |
| US2002/0111619(A1) | 2002-08-01 | Keast et al. | Applicant |
| US2002/0111647(A1) | 2002-08-01 | Khairkhahan et al. | Applicant |
| US2002/0183827(A1) | 2002-12-01 | Derus et al. | Applicant |
| US2003/0014104(A1) | 2003-01-01 | Cribier | Applicant |
| US2003/0040792(A1) | 2003-02-01 | Gabbay | Applicant |
| US2003/0083679(A1) | 2003-05-01 | Grudem et al. | Applicant |
| US2003/0105517(A1) | 2003-06-01 | White et al. | Applicant |
| US2003/0109924(A1) | 2003-06-01 | Cribier | Applicant |
| US2003/0114913(A1) | 2003-06-01 | Spenser et al. | Applicant |
| US2003/0120263(A1) | 2003-06-01 | Ouriel et al. | Applicant |
| US2003/0120330(A1) | 2003-06-01 | Ouriel et al. | Applicant |
| US2003/0120333(A1) | 2003-06-01 | Ouriel et al. | Applicant |
| US2003/0130729(A1) | 2003-07-01 | Paniagua | Applicant |
| US2003/0176914(A1) | 2003-09-01 | Rabkin et al. | Applicant |
| US2003/0187499(A1) | 2003-10-01 | Swanson et al. | Applicant |
| US2003/0199971(A1) | 2003-10-01 | Tower et al. | Applicant |
| US2003/0220683(A1) | 2003-11-01 | Minasian et al. | Applicant |
| US2004/0039436(A1) | 2004-02-01 | Spenser et al. | Applicant |
| US2004/0087900(A1) | 2004-05-01 | Thompson et al. | Applicant |
| US2004/0093058(A1) | 2004-05-01 | Cottone et al. | Applicant |
| US2004/0093060(A1) | 2004-05-01 | Seguin et al. | Applicant |
| US2004/0102842(A1) | 2004-05-01 | Jansen | Applicant |
| US2004/0117009(A1) | 2004-06-01 | Cali et al. | Applicant |
| US2004/0133273(A1) | 2004-07-01 | Cox | Applicant |
| US2004/0186561(A1) | 2004-09-01 | McGuckin, Jr. et al. | Applicant |
| US2004/0193261(A1) | 2004-09-01 | Berreklou | Applicant |
| US2004/0210304(A1) | 2004-10-01 | Seguin et al. | Applicant |
| US2004/0210307(A1) | 2004-10-01 | Khairkhahan | Applicant |
| US2004/0215325(A1) | 2004-10-01 | Penn et al. | Applicant |
| US2004/0225353(A1) | 2004-11-01 | McGuckin, Jr. et al. | Applicant |
| US2004/0236411(A1) | 2004-11-01 | Sarac et al. | Applicant |
| US2004/0243230(A1) | 2004-12-01 | Navia et al. | Applicant |
| US2004/0249433(A1) | 2004-12-01 | Freitag | Applicant |
| US2005/0033398(A1) | 2005-02-01 | Seguin | Applicant |
| US2005/0038470(A1) | 2005-02-01 | van der Burg et al. | Applicant |
| US2005/0075727(A1) | 2005-04-01 | Wheatley | Applicant |
| US2005/0090887(A1) | 2005-04-01 | Pryor | Applicant |
| US2005/0096738(A1) | 2005-05-01 | Cali et al. | Applicant |
| US2005/0107872(A1) | 2005-05-01 | Mensah et al. | Applicant |
| US2005/0125020(A1) | 2005-06-01 | Meade et al. | Applicant |
| US2005/0137682(A1) | 2005-06-01 | Justino | Applicant |
| US2005/0137686(A1) | 2005-06-01 | Salahieh et al. | Applicant |
| US2005/0137687(A1) | 2005-06-01 | Salahieh et al. | Applicant |
| US2005/0137690(A1) | 2005-06-01 | Salahieh et al. | Applicant |
| US2005/0137691(A1) | 2005-06-01 | Salahieh et al. | Applicant |
| US2005/0137693(A1) | 2005-06-01 | Haug et al. | Applicant |
| US2005/0137695(A1) | 2005-06-01 | Salahieh et al. | Applicant |
| US2005/0137701(A1) | 2005-06-01 | Salahieh et al. | Applicant |
| US2005/0154444(A1) | 2005-07-01 | Quadri | Applicant |
| US2005/0159811(A1) | 2005-07-01 | Lane | Applicant |
| US2005/0182483(A1) | 2005-08-01 | Osborne et al. | Applicant |
| US2005/0182486(A1) | 2005-08-01 | Gabbay | Applicant |
| US2005/0203616(A1) | 2005-09-01 | Cribier | Applicant |
| US2005/0203618(A1) | 2005-09-01 | Sharkawy et al. | Applicant |
| US2005/0216079(A1) | 2005-09-01 | Macoviak | Applicant |
| US2005/0234546(A1) | 2005-10-01 | Nugent et al. | Applicant |
| US2005/0240204(A1) | 2005-10-01 | Grudem et al. | Applicant |
| US2005/0251251(A1) | 2005-11-01 | Cribier | Applicant |
| US2005/0283231(A1) | 2005-12-01 | Haug et al. | Applicant |
| US2006/0020247(A1) | 2006-01-01 | Kagan et al. | Applicant |
| US2006/0020327(A1) | 2006-01-01 | Lashinski et al. | Applicant |
| US2006/0020334(A1) | 2006-01-01 | Lashinski et al. | Applicant |
| US2006/0052802(A1) | 2006-03-01 | Sterman et al. | Applicant |
| US2006/0052867(A1) | 2006-03-01 | Revuelta et al. | Applicant |
| US2006/0058872(A1) | 2006-03-01 | Salahieh et al. | Applicant |
| US2006/0095115(A1) | 2006-05-01 | Bladillah et al. | Applicant |
| US2006/0106454(A1) | 2006-05-01 | Osborne et al. | Applicant |
| US2006/0116625(A1) | 2006-06-01 | Renati et al. | Applicant |
| US2006/0129235(A1) | 2006-06-01 | Seguin et al. | Applicant |
| US2006/0149360(A1) | 2006-07-01 | Schwammenthal et al. | Applicant |
| US2006/0161265(A1) | 2006-07-01 | Levine et al. | Applicant |
| US2006/0173537(A1) | 2006-08-01 | Yang et al. | Applicant |
| US2006/0195183(A1) | 2006-08-01 | Navia et al. | Applicant |
| US2006/0212110(A1) | 2006-09-01 | Osborne et al. | Applicant |
| US2006/0224232(A1) | 2006-10-01 | Chobotov | Applicant |
| US2006/0241745(A1) | 2006-10-01 | Solem | Applicant |
| US2006/0253191(A1) | 2006-11-01 | Salahieh et al. | Applicant |
| US2006/0259135(A1) | 2006-11-01 | Navia et al. | Applicant |
| US2006/0259136(A1) | 2006-11-01 | Nguyen et al. | Applicant |
| US2006/0265056(A1) | 2006-11-01 | Nguyen et al. | Applicant |
| US2006/0287717(A1) | 2006-12-01 | Rowe et al. | Applicant |
| US2006/0287719(A1) | 2006-12-01 | Rowe et al. | Applicant |
| US2006/0293745(A1) | 2006-12-01 | Carpentier et al. | Applicant |
| US2007/0010876(A1) | 2007-01-01 | Salahieh et al. | Applicant |
| US2007/0016286(A1) | 2007-01-01 | Hermann et al. | Applicant |
| US2007/0043435(A1) | 2007-02-01 | Seguin et al. | Applicant |
| US2007/0050021(A1) | 2007-03-01 | Johnson | Applicant |
| US2007/0067016(A1) | 2007-03-01 | Jung | Applicant |
| US2007/0100432(A1) | 2007-05-01 | Case et al. | Applicant |
| US2007/0118206(A1) | 2007-05-01 | Colgan et al. | Applicant |
| US2007/0118207(A1) | 2007-05-01 | Amplatz et al. | Applicant |
| US2007/0123798(A1) | 2007-05-01 | Rahamimov | Applicant |
| US2007/0129794(A1) | 2007-06-01 | Realyvasquez | Applicant |
| US2007/0142906(A1) | 2007-06-01 | Figulla et al. | Applicant |
| US2007/0162107(A1) | 2007-07-01 | Haug et al. | Applicant |
| US2007/0185559(A1) | 2007-08-01 | Shelso | Applicant |
| US2007/0213813(A1) | 2007-09-01 | Von Segesser et al. | Applicant |
| US2007/0219620(A1) | 2007-09-01 | Eells et al. | Applicant |
| US2007/0233228(A1) | 2007-10-01 | Eberhardt et al. | Applicant |
| US2007/0250151(A1) | 2007-10-01 | Pereira | Applicant |
| US2007/0255391(A1) | 2007-11-01 | Hojeibane et al. | Applicant |
| US2007/0255394(A1) | 2007-11-01 | Ryan | Applicant |
| US2007/0270932(A1) | 2007-11-01 | Headley et al. | Applicant |
| US2007/0270937(A1) | 2007-11-01 | Leanna | Applicant |
| US2007/0293940(A1) | 2007-12-01 | Schaeffer et al. | Applicant |
| US2008/0009934(A1) | 2008-01-01 | Schneider et al. | Applicant |
| US2008/0021546(A1) | 2008-01-01 | Patz et al. | Applicant |
| US2008/0071361(A1) | 2008-03-01 | Tuval et al. | Applicant |
| US2008/0071363(A1) | 2008-03-01 | Tuval et al. | Applicant |
| US2008/0071366(A1) | 2008-03-01 | Tuval et al. | Applicant |
| US2008/0071369(A1) | 2008-03-01 | Tuval et al. | Applicant |
| US2008/0082164(A1) | 2008-04-01 | Friedman | Applicant |
| US2008/0082165(A1) | 2008-04-01 | Wilson et al. | Applicant |
| US2008/0082166(A1) | 2008-04-01 | Styrc et al. | Applicant |
| US2008/0097571(A1) | 2008-04-01 | Denison et al. | Applicant |
| US2008/0097581(A1) | 2008-04-01 | Shanley | Applicant |
| US2008/0114441(A1) | 2008-05-01 | Rust et al. | Applicant |
| US2008/0125853(A1) | 2008-05-01 | Boyle et al. | Applicant |
| US2008/0125859(A1) | 2008-05-01 | Salahieh et al. | Applicant |
| US2008/0133003(A1) | 2008-06-01 | Seguin | Applicant |
| US2008/0140189(A1) | 2008-06-01 | Nguyen et al. | Applicant |
| US2008/0147179(A1) | 2008-06-01 | Cai et al. | Applicant |
| US2008/0147183(A1) | 2008-06-01 | Styrc | Applicant |
| US2008/0161911(A1) | 2008-07-01 | Revuelta et al. | Applicant |
| US2008/0177381(A1) | 2008-07-01 | Navia et al. | Applicant |
| US2008/0183273(A1) | 2008-07-01 | Mesana et al. | Applicant |
| US2008/0208307(A1) | 2008-08-01 | Ben-Muvhar et al. | Applicant |
| US2008/0208328(A1) | 2008-08-01 | Antocci et al. | Applicant |
| US2008/0208332(A1) | 2008-08-01 | Lamphere et al. | Applicant |
| US2008/0221672(A1) | 2008-09-01 | Lamphere et al. | Applicant |
| US2008/0228254(A1) | 2008-09-01 | Ryan | Applicant |
| US2008/0243233(A1) | 2008-10-01 | Ben-Muvhar et al. | Applicant |
| US2008/0243245(A1) | 2008-10-01 | Thambar et al. | Applicant |
| US2008/0262596(A1) | 2008-10-01 | Xiao | Applicant |
| US2008/0269878(A1) | 2008-10-01 | Iobbi | Applicant |
| US2008/0275549(A1) | 2008-11-01 | Rowe | Applicant |
| US2008/0275550(A1) | 2008-11-01 | Kheradvar et al. | Applicant |
| US2009/0005863(A1) | 2009-01-01 | Goetz et al. | Applicant |
| US2009/0012602(A1) | 2009-01-01 | Quadri | Applicant |
| US2009/0054976(A1) | 2009-02-01 | Tuval et al. | Applicant |
| US2009/0062908(A1) | 2009-03-01 | Bonhoeffer et al. | Applicant |
| US2009/0076585(A1) | 2009-03-01 | Hendriksen | Applicant |
| US2009/0076598(A1) | 2009-03-01 | Salahieh et al. | Applicant |
| US2009/0082844(A1) | 2009-03-01 | Zacharias et al. | Applicant |
| US2009/0082847(A1) | 2009-03-01 | Zacharias et al. | Applicant |
| US2009/0088832(A1) | 2009-04-01 | Chew et al. | Applicant |
| US2009/0088836(A1) | 2009-04-01 | Bishop et al. | Applicant |
| US2009/0099643(A1) | 2009-04-01 | Hyodoh et al. | Applicant |
| US2009/0099653(A1) | 2009-04-01 | Suri et al. | Applicant |
| US2009/0125096(A1) | 2009-05-01 | Chu et al. | Applicant |
| US2009/0125104(A1) | 2009-05-01 | Hoffman | Applicant |
| US2009/0132035(A1) | 2009-05-01 | Roth et al. | Applicant |
| US2009/0132037(A1) | 2009-05-01 | Hoffman et al. | Applicant |
| US2009/0138069(A1) | 2009-05-01 | Hoffman | Applicant |
| US2009/0138079(A1) | 2009-05-01 | Tuval et al. | Applicant |
| US2009/0149946(A1) | 2009-06-01 | Dixon | Applicant |
| US2009/0157175(A1) | 2009-06-01 | Benichou | Applicant |
| US2009/0163934(A1) | 2009-06-01 | Raschdorf et al. | Applicant |
| US2009/0171438(A1) | 2009-07-01 | Chuter et al. | Applicant |
| US2009/0171456(A1) | 2009-07-01 | Kveen et al. | Applicant |
| US2009/0177262(A1) | 2009-07-01 | Oberti et al. | Applicant |
| US2009/0182407(A1) | 2009-07-01 | Leanna et al. | Applicant |
| US2009/0182413(A1) | 2009-07-01 | Burkart et al. | Examiner |
| US2009/0188964(A1) | 2009-07-01 | Orlov | Applicant |
| US2009/0192601(A1) | 2009-07-01 | Rafiee et al. | Applicant |
| US2009/0216314(A1) | 2009-08-01 | Quadri | Applicant |
| US2009/0234443(A1) | 2009-09-01 | Ottma et al. | Applicant |
| US2009/0248132(A1) | 2009-10-01 | Bloom et al. | Applicant |
| US2009/0248133(A1) | 2009-10-01 | Bloom et al. | Applicant |
| US2009/0264997(A1) | 2009-10-01 | Salahieh et al. | Applicant |
| US2009/0270972(A1) | 2009-10-01 | Lane | Applicant |
| US2009/0276040(A1) | 2009-11-01 | Rowe et al. | Applicant |
| US2009/0281618(A1) | 2009-11-01 | Hill et al. | Applicant |
| US2009/0281619(A1) | 2009-11-01 | Le et al. | Applicant |
| US2009/0287296(A1) | 2009-11-01 | Manasse | Applicant |
| US2009/0287299(A1) | 2009-11-01 | Tabor et al. | Applicant |
| US2009/0292350(A1) | 2009-11-01 | Eberhardt et al. | Applicant |
| US2009/0306768(A1) | 2009-12-01 | Quadri | Applicant |
| US2010/0004740(A1) | 2010-01-01 | Sequin et al. | Applicant |
| US2010/0036479(A1) | 2010-02-01 | Hill et al. | Applicant |
| US2010/0049306(A1) | 2010-02-01 | House et al. | Applicant |
| US2010/0082089(A1) | 2010-04-01 | Quadri et al. | Applicant |
| US2010/0082094(A1) | 2010-04-01 | Quadri et al. | Applicant |
| US2010/0094411(A1) | 2010-04-01 | Tuval et al. | Applicant |
| US2010/0114299(A1) | 2010-05-01 | Ben Muvhar et al. | Applicant |
| US2010/0114305(A1) | 2010-05-01 | Kang et al. | Applicant |
| US2010/0121461(A1) | 2010-05-01 | Sobrino-Serrano et al. | Applicant |
| US2010/0161027(A1) | 2010-06-01 | Orr | Applicant |
| US2010/0179633(A1) | 2010-07-01 | Solem | Applicant |
| US2010/0179647(A1) | 2010-07-01 | Carpenter et al. | Applicant |
| US2010/0191326(A1) | 2010-07-01 | Alkhatib | Applicant |
| US2010/0217382(A1) | 2010-08-01 | Chau et al. | Applicant |
| US2010/0249894(A1) | 2010-09-01 | Oba et al. | Applicant |
| US2010/0249911(A1) | 2010-09-01 | Alkhatib | Applicant |
| US2010/0256723(A1) | 2010-10-01 | Murray | Applicant |
| US2010/0262157(A1) | 2010-10-01 | Silver et al. | Applicant |
| US2010/0274345(A1) | 2010-10-01 | Rust | Applicant |
| US2010/0280606(A1) | 2010-11-01 | Naor | Applicant |
| US2010/0298931(A1) | 2010-11-01 | Quadri et al. | Applicant |
| US2010/0305685(A1) | 2010-12-01 | Millwee et al. | Applicant |
| US2010/0312333(A1) | 2010-12-01 | Navia et al. | Applicant |
| US2011/0004296(A1) | 2011-01-01 | Lutter et al. | Applicant |
| US2011/0022157(A1) | 2011-01-01 | Essinger et al. | Applicant |
| US2011/0022164(A1) | 2011-01-01 | Quinn et al. | Applicant |
| US2011/0022165(A1) | 2011-01-01 | Oba et al. | Applicant |
| US2011/0022166(A1) | 2011-01-01 | Dahlgren et al. | Applicant |
| US2011/0022169(A1) | 2011-01-01 | Ryan et al. | Applicant |
| US2011/0029067(A1) | 2011-02-01 | McGuckin, Jr. et al. | Applicant |
| US2011/0137397(A1) | 2011-06-01 | Chau et al. | Applicant |
| US2011/0166644(A1) | 2011-07-01 | Keeble et al. | Applicant |
| US2011/0178597(A9) | 2011-07-01 | Navia et al. | Applicant |
| US2011/0208297(A1) | 2011-08-01 | Tuval et al. | Applicant |
| US2011/0208298(A1) | 2011-08-01 | Tuval et al. | Applicant |
| US2011/0218619(A1) | 2011-09-01 | Benichou et al. | Applicant |
| US2011/0224780(A1) | 2011-09-01 | Tabor et al. | Applicant |
| US2011/0224785(A1) | 2011-09-01 | Hacohen | Applicant |
| US2011/0264196(A1) | 2011-10-01 | Savage et al. | Applicant |
| US2011/0313515(A1) | 2011-12-01 | Quadri et al. | Applicant |
| US2011/0319989(A1) | 2011-12-01 | Lane et al. | Applicant |
| US2012/0016411(A1) | 2012-01-01 | Tuval | Applicant |
| US2012/0022639(A1) | 2012-01-01 | Hacohen et al. | Applicant |
| US2012/0022640(A1) | 2012-01-01 | Gross et al. | Applicant |
| US2012/0041550(A1) | 2012-02-01 | Salahieh et al. | Applicant |
| US2012/0059452(A1) | 2012-03-01 | Boucher et al. | Applicant |
| US2012/0059454(A1) | 2012-03-01 | Millwee et al. | Applicant |
| US2012/0078353(A1) | 2012-03-01 | Quadri et al. | Applicant |
| US2012/0078360(A1) | 2012-03-01 | Rafiee | Examiner |
| US2012/0101571(A1) | 2012-04-01 | Thambar et al. | Applicant |
| US2012/0101572(A1) | 2012-04-01 | Kovalsky et al. | Applicant |
| US2012/0123529(A1) | 2012-05-01 | Levi et al. | Applicant |
| US2012/0179239(A1) | 2012-07-01 | Quadri et al. | Applicant |
| US2012/0215303(A1) | 2012-08-01 | Quadri et al. | Applicant |
| US2012/0259405(A1) | 2012-10-01 | Weber et al. | Applicant |
| US2012/0271398(A1) | 2012-10-01 | Essinger et al. | Applicant |
| US2012/0283824(A1) | 2012-11-01 | Lutter et al. | Applicant |
| US2012/0290062(A1) | 2012-11-01 | McNamara et al. | Applicant |
| US2012/0296418(A1) | 2012-11-01 | Bonyuet et al. | Applicant |
| US2012/0303116(A1) | 2012-11-01 | Gorman, III | Examiner |
| US2012/0310328(A1) | 2012-12-01 | Olson et al. | Applicant |
| US2012/0323316(A1) | 2012-12-01 | Chau et al. | Applicant |
| US2013/0006294(A1) | 2013-01-01 | Kashkarov | Applicant |
| US2013/0018458(A1) | 2013-01-01 | Yohanan et al. | Applicant |
| US2013/0053950(A1) | 2013-02-01 | Rowe et al. | Applicant |
| US2013/0110227(A1) | 2013-05-01 | Quadri et al. | Applicant |
| US2013/0131788(A1) | 2013-05-01 | Quadri et al. | Applicant |
| US2013/0131793(A1) | 2013-05-01 | Quadri et al. | Applicant |
| US2013/0138203(A1) | 2013-05-01 | Quadri et al. | Applicant |
| US2013/0138207(A1) | 2013-05-01 | Quadri et al. | Applicant |
| US2013/0144375(A1) | 2013-06-01 | Giasolli et al. | Applicant |
| US2013/0144378(A1) | 2013-06-01 | Quadri et al. | Applicant |
| US2013/0144380(A1) | 2013-06-01 | Quadri et al. | Applicant |
| US2013/0144381(A1) | 2013-06-01 | Quadri et al. | Applicant |
| US2013/0150956(A1) | 2013-06-01 | Yohanan et al. | Applicant |
| US2013/0172983(A1) | 2013-07-01 | Clerc et al. | Applicant |
| US2013/0184811(A1) | 2013-07-01 | Rowe et al. | Applicant |
| US2013/0184813(A1) | 2013-07-01 | Quadri et al. | Applicant |
| US2013/0190861(A1) | 2013-07-01 | Chau et al. | Applicant |
| US2013/0211508(A1) | 2013-08-01 | Lane | Examiner |
| US2013/0253635(A1) | 2013-09-01 | Straubinger et al. | Applicant |
| US2013/0253642(A1) | 2013-09-01 | Brecker | Applicant |
| US2013/0261737(A1) | 2013-10-01 | Costello | Applicant |
| US2013/0304200(A1) | 2013-11-01 | McLean et al. | Applicant |
| US2013/0310928(A1) | 2013-11-01 | Morriss | Examiner |
| US2013/0345786(A1) | 2013-12-01 | Behan | Applicant |
| US2014/0005764(A1) | 2014-01-01 | Schroeder | Applicant |
| US2014/0018912(A1) | 2014-01-01 | Delaloye et al. | Applicant |
| US2014/0039611(A1) | 2014-02-01 | Lane et al. | Applicant |
| US2014/0046427(A1) | 2014-02-01 | Michalak | Applicant |
| US2014/0052237(A1) | 2014-02-01 | Lane et al. | Applicant |
| US2014/0052242(A1) | 2014-02-01 | Revuelta et al. | Applicant |
| US2014/0067054(A1) | 2014-03-01 | Chau et al. | Applicant |
| US2014/0088685(A1) | 2014-03-01 | Yevzlin et al. | Applicant |
| US2014/0100651(A1) | 2014-04-01 | Kheradvar et al. | Applicant |
| US2014/0100653(A1) | 2014-04-01 | Savage et al. | Applicant |
| US2014/0142694(A1) | 2014-05-01 | Tabor et al. | Applicant |
| US2014/0155990(A1) | 2014-06-01 | Nyuli et al. | Applicant |
| US2014/0163668(A1) | 2014-06-01 | Rafiee | Examiner |
| US2014/0172083(A1) | 2014-06-01 | Bruchman et al. | Applicant |
| US2014/0172085(A1) | 2014-06-01 | Quadri et al. | Applicant |
| US2014/0172086(A1) | 2014-06-01 | Quadri et al. | Applicant |
| US2014/0194981(A1) | 2014-07-01 | Menk et al. | Applicant |
| US2014/0194983(A1) | 2014-07-01 | Kovalsky et al. | Applicant |
| US2014/0214153(A1) | 2014-07-01 | Ottma et al. | Applicant |
| US2014/0214154(A1) | 2014-07-01 | Nguyen et al. | Applicant |
| US2014/0214155(A1) | 2014-07-01 | Kelley | Applicant |
| US2014/0214159(A1) | 2014-07-01 | Vidlund et al. | Applicant |
| US2014/0214160(A1) | 2014-07-01 | Naor | Applicant |
| US2014/0222136(A1) | 2014-08-01 | Geist et al. | Applicant |
| US2014/0222139(A1) | 2014-08-01 | Nguyen et al. | Applicant |
| US2014/0222142(A1) | 2014-08-01 | Kovalsky et al. | Applicant |
| US2014/0236288(A1) | 2014-08-01 | Lambrecht et al. | Applicant |
| US2014/0243966(A1) | 2014-08-01 | Garde et al. | Applicant |
| US2014/0257467(A1) | 2014-09-01 | Lane et al. | Applicant |
| US2014/0257476(A1) | 2014-09-01 | Montorfano et al. | Applicant |
| US2014/0277390(A1) | 2014-09-01 | Ratz et al. | Applicant |
| US2014/0277402(A1) | 2014-09-01 | Essinger et al. | Applicant |
| US2014/0277422(A1) | 2014-09-01 | Ratz et al. | Applicant |
| US2014/0277423(A1) | 2014-09-01 | Alkhatib et al. | Applicant |
| US2014/0277427(A1) | 2014-09-01 | Ratz et al. | Applicant |
| US2014/0296973(A1) | 2014-10-01 | Bergheim et al. | Applicant |
| US2014/0296975(A1) | 2014-10-01 | Tegels et al. | Applicant |
| US2014/0303719(A1) | 2014-10-01 | Cox et al. | Applicant |
| US2014/0309728(A1) | 2014-10-01 | Dehdashtian et al. | Applicant |
| US2014/0309731(A1) | 2014-10-01 | Quadri et al. | Applicant |
| US2014/0309732(A1) | 2014-10-01 | Solem | Applicant |
| US2014/0324160(A1) | 2014-10-01 | Benichou et al. | Applicant |
| US2014/0324164(A1) | 2014-10-01 | Gross et al. | Applicant |
| US2014/0330368(A1) | 2014-11-01 | Gloss et al. | Applicant |
| US2014/0330371(A1) | 2014-11-01 | Gloss et al. | Applicant |
| US2014/0330372(A1) | 2014-11-01 | Weston et al. | Applicant |
| US2014/0331475(A1) | 2014-11-01 | Duffy et al. | Applicant |
| US2014/0336754(A1) | 2014-11-01 | Gurskis et al. | Applicant |
| US2014/0343669(A1) | 2014-11-01 | Lane et al. | Applicant |
| US2014/0343670(A1) | 2014-11-01 | Bakis et al. | Applicant |
| US2014/0343671(A1) | 2014-11-01 | Yohanan et al. | Applicant |
| US2014/0350666(A1) | 2014-11-01 | Righini | Applicant |
| US2014/0350668(A1) | 2014-11-01 | Delaloye et al. | Applicant |
| US2014/0358221(A1) | 2014-12-01 | Ho et al. | Applicant |
| US2014/0364939(A1) | 2014-12-01 | Deshmukh et al. | Applicant |
| US2014/0364943(A1) | 2014-12-01 | Conklin | Applicant |
| US2014/0364944(A1) | 2014-12-01 | Lutter et al. | Applicant |
| US2014/0371842(A1) | 2014-12-01 | Marquez et al. | Applicant |
| US2014/0371845(A1) | 2014-12-01 | Tuval et al. | Applicant |
| US2014/0371847(A1) | 2014-12-01 | Madrid et al. | Applicant |
| US2014/0371848(A1) | 2014-12-01 | Murray, III et al. | Applicant |
| US2014/0379067(A1) | 2014-12-01 | Nguyen et al. | Applicant |
| US2014/0379068(A1) | 2014-12-01 | Thielen et al. | Applicant |
| US2014/0379077(A1) | 2014-12-01 | Tuval et al. | Applicant |
| US2015/0005873(A1) | 2015-01-01 | Chang et al. | Applicant |
| US2015/0012085(A1) | 2015-01-01 | Salahieh et al. | Applicant |
| US2015/0018938(A1) | 2015-01-01 | Von Segesser et al. | Applicant |
| US2015/0018944(A1) | 2015-01-01 | O'Connell et al. | Applicant |
| US2015/0032153(A1) | 2015-01-01 | Quadri et al. | Applicant |
| US2015/0066140(A1) | 2015-03-01 | Quadri | Applicant |
| US2015/0081009(A1) | 2015-03-01 | Quadri | Applicant |
| US2015/0142100(A1) | 2015-05-01 | Morriss | Examiner |
| US2015/0142103(A1) | 2015-05-01 | Vidlund | Applicant |
| US2015/0148731(A1) | 2015-05-01 | McNamara et al. | Applicant |
| US2015/0157458(A1) | 2015-06-01 | Thambar et al. | Applicant |
| US2015/0196390(A1) | 2015-07-01 | Ma et al. | Applicant |
| CA2304325(A1) | 2000-10-01 | Applicant | |
| CA2827556(A1) | 2012-07-01 | Applicant | |
| DE3128704 | 1983-02-01 | Applicant | |
| DE102006052564 | 2007-12-01 | Applicant | |
| EP657147 | 1995-06-01 | Applicant | |
| EP147996(B1) | 2004-11-01 | Applicant | |
| EP1255510(B1) | 2007-04-01 | Applicant | |
| EP1772104(A2) | 2007-04-01 | Applicant | |
| GB1264471 | 1972-02-01 | Applicant | |
| GB1315844 | 1973-05-01 | Applicant | |
| GB2245495 | 1992-01-01 | Applicant | |
| GB2398245 | 2004-08-01 | Applicant | |
| JP2002-540889 | 2002-12-01 | Applicant | |
| JP2008-541865 | 2008-11-01 | Applicant | |
| WO97/49355 | 1997-12-01 | Applicant | |
| WO/53104 | 2000-09-01 | Applicant | |
| WO/61034 | 2000-10-01 | Applicant | |
| WO1/35861 | 2001-05-01 | Applicant | |
| WO1/35870 | 2001-05-01 | Applicant | |
| WO1/72239 | 2001-10-01 | Applicant | |
| WO2/36048 | 2002-05-01 | Applicant | |
| WO3/092554 | 2003-11-01 | Applicant | |
| WO3/028522 | 2004-01-01 | Applicant | |
| WO2004/014257 | 2004-02-01 | Applicant | |
| WO2004/014474 | 2004-02-01 | Applicant | |
| WO2004/058097 | 2004-07-01 | Applicant | |
| WO2005/011534 | 2005-02-01 | Applicant | |
| WO2005/041810 | 2005-05-01 | Applicant | |
| WO2005/087140 | 2005-09-01 | Applicant | |
| WO2006/070372 | 2006-07-01 | Applicant | |
| WO2006/085304 | 2006-08-01 | Applicant | |
| WO2006/089236 | 2006-08-01 | Applicant | |
| WO2006/127765 | 2006-11-01 | Applicant | |
| WO2007/025028 | 2007-03-01 | Applicant | |
| WO2007/034488 | 2007-03-01 | Applicant | |
| WO2007/058857 | 2007-05-01 | Applicant | |
| WO2007/123658 | 2007-11-01 | Applicant | |
| WO2007/134290 | 2007-11-01 | Applicant | |
| WO2008/005535 | 2008-01-01 | Applicant | |
| WO2008/013915 | 2008-01-01 | Applicant | |
| WO2008/070797 | 2008-06-01 | Applicant | |
| WO2008/091515 | 2008-07-01 | Applicant | |
| WO2008/103722 | 2008-08-01 | Applicant | |
| WO2008/150529 | 2008-12-01 | Applicant | |
| WO2009/026563 | 2009-02-01 | Applicant | |
| WO2009/033469 | 2009-03-01 | Applicant | |
| WO2009/045331 | 2009-04-01 | Applicant | |
| WO2009/052188 | 2009-04-01 | Applicant | |
| WO2009/053497 | 2009-04-01 | Applicant | |
| WO2009/091509 | 2009-07-01 | Applicant | |
| WO2009/094500 | 2009-07-01 | Applicant | |
| WO2009/134701 | 2009-11-01 | Applicant | |
| WO2009/137359 | 2009-11-01 | Applicant | |
| WO2009/155561 | 2009-12-01 | Applicant | |
| WO2010/008549 | 2010-01-01 | Applicant | |
| WO2010/037141 | 2010-04-01 | Applicant | |
| WO2010/040009 | 2010-04-01 | Applicant | |
| WO2010/057262 | 2010-05-01 | Applicant | |
| WO2010/098857 | 2010-09-01 | Applicant | |
| WO2009/149462 | 2011-01-01 | Applicant | |
| WO2010/138853 | 2011-02-01 | Applicant | |
| WO2011/025945 | 2011-03-01 | Applicant | |
| WO2011/137531 | 2011-11-01 | Applicant | |
| WO2011/109801 | 2012-01-01 | Applicant | |
| WO2011/109813 | 2012-01-01 | Applicant | |
| WO2012/035279 | 2012-03-01 | Applicant | |
| WO2012/162228 | 2012-11-01 | Applicant | |
| WO2012/177942 | 2012-12-01 | Applicant | |
| WO2013/028387 | 2013-02-01 | Applicant | |
| WO2013/012801 | 2013-04-01 | Applicant | |
| WO2013/086413 | 2013-06-01 | Applicant |
Non-Patent Literature (78)
- US 8,062,357, 11/2011, Salahieh et al. (withdrawn)Applicant
- U.S. Appl. No. 14/186,989, filed Feb. 21, 2014, Quadri et al.Applicant
- U.S. Appl. No. 14/197,639, filed Mar. 5, 2014, Ratz et al.Applicant
- U.S. Appl. No. 14/197,690, filed Mar. 5, 2014, Ratz et al.Applicant
- U.S. Appl. No. 29,484,001, filed Mar. 5, 2014, Pesce et al.Applicant
- CardiAQ Valve Technologies, “Innovations in Heart Valve Therapy,” In3 San Francisco, Jun. 18, 2008, PowerPoint presentation in 19 slides.Applicant
- European Extended Search Report, re EP Application No. 14159271.7, dated Jul. 23, 2014.Applicant
- European Extended Search Report, re EP Application No. 14159378.0, dated Jul. 24, 2014.Applicant
- European Extended Search Report, re EP Application No. 14159090.1, dated Jul. 22, 2014.Applicant
- U.S. Appl. No. 61/331,799, filed May 5, 2010, Lane et al.Applicant
- U.S. Appl. No. 61/393,860, filed Oct. 15, 2010, Lane et al.Applicant
- U.S. Appl. No. 61/414,879, filed Nov. 17, 2010, Lane et al.Applicant
- U.S. Appl. No. 14/598,568, filed Jan. 16, 2015, Quadri et al.Applicant
- U.S. Appl. No. 14/628,034, filed Feb. 20, 2015, Rabito et al.Applicant
- U.S. Appl. No. 14/702,233, filed May 1, 2015, Arshad et al.Applicant
- U.S. Appl. No. 14/716,507, filed May 19, 2015, Ratz et al.Applicant
- Neovasc Surgical Products, “Neovasc Surgical Products: An Operating Division of Neovasc Inc.,” dated Apr. 2009.Applicant
- Kronemyer, Bob: “CardiAQ Valve Technologies: Percutaneous Mitral Valve Replacement,” Start Up—Windhover Review of Emerging Medical Ventures, vol. 14, Issue No. 6, Jun. 2009, pp. 48-49.Applicant
- Bavaria, Joseph E. M.D.: “CardiAQ Valve Technologies: Transcatheter Mitral Valve Implantation,” Sep. 21, 2009.Applicant
- Ostrovsky, Gene: “Transcatheter Mitral Valve Implantation Technology from CardiAQ,” medGadget, Jan. 15, 2010, available at: http://www.medgadget.com/2010/01/transcatheter—mitral—valve—implantation—technology—from—cardiaq.html.Applicant
- “Company Overview,” Jun. 25, 2009 at TVT.Applicant
- “Update,” Applicant believes this may have been presented on Jun. 6, 2010 at TVT.Applicant
- Banai, Shmuel, et al., Tiara: A Novel Catheter-Based Mitral Valve Bioprosthesis, Initial Experiments and Short-Term Pre-Clinical Results, Journal of the American College of Cardiology, vol. 60, No. 15, 2012. Applicant believes that this may have been available online as early as Sep. 12, 2012.Applicant
- Berreklouw, Eric, MD, PhD, et al., “Sutureless Mitral Valve Replacement With Bioprostheses and Nitinol Attachment Rings: Feasibility in Acute Pig Experiments,” The Journal of Thoracic and Cardiovascular Surgery, vol. 142, No. 2, Aug. 2011 in 7 pages, Applicant believes this may have been available online as early as Feb. 4, 2011.Applicant
- Boudjemline, Younes, MD, et al., “Steps Toward the Percutaneous Replacement of Atrioventricular Valves,” JACC, vol. 46, No. 2, Jul. 19, 2005:360-5.Applicant
- Brinkman, William T., MD, et al., Transcatheter Cardiac Valve Interventions, Surg Clin N Am 89 (2009) 951-966, Applicant believes this may have been available as early as Aug. 2009.Applicant
- Chiam, Paul T.L., et al., “Percutaneous Transcatheter Aortic Valve Implantation: Assessing Results, Judging Outcomes, and Planning Trials,” JACC: Cardiovascular Interventions, The American College of Cardiology Foundation, vol. 1, No. 4, Aug. 2008:341-50.Applicant
- Condado, Jose Antonio, et al., “Percutaneous Treatment of Heart Valves,” Rev Esp Cardio. 2006;59(12):1225-31, Applicant believes this may have been available as early as Dec. 2006.Applicant
- Engager System, Precise Valve Positioning, Transcatheter Aortic Valve Implantation System, Transcatheter Aortic Valve Replacement—TAVR I Medtronic Engager, http://www.medtronic-engager.com/home/transcatheter-aortic-valve-repl., 2014 Medtronic, Inc. in 2 pages. Applicant believes this may have been available online as early as Aug. 25, 2013.Applicant
- Fanning, Jonathon P., et al., “Transcatheter Aortic Valve Implantation (TAVI): Valve Design and Evolution,” International Journal of Cardiology 168 (2013) 1822-1831, Applicant believes this may have been available as early as Aug. 20, 2013.Applicant
- Fitzgerald, Peter J. M.D., “Tomorrow's Technology: Percutaneous Mitral Valve Replacement, Chordal Shortening, and Beyond,” Transcatheter Valve Therapies (TVT) Conference. Seattle, WA. Applicant believes this may have been available as early as Jun. 7, 2010.Applicant
- Gillespie, Matthew J., MD, et al., “Sutureless Mitral Valve Replacement: Initial Steps Toward a Percutaneous Procedure,” Ann Thorac Surg. Aug. 2013; 96(2).Applicant
- Grube, Eberhard, MD, et al., “Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease, The Siegburg First-in-Man Study” Journal of the American Heart Association, 2006; 114:1616-1624, originally published online Oct. 2, 2006.Applicant
- JenaValve Technology, “The JenaValve—The Prosthesis”, 2011 JenaValve Technology in 1 page.Applicant
- Karimi, Houshang, MD, et al., “Percutaneous Valve Therapies,” SIS 2007 Yearbook, Chapter 11, pp. 1-11.Applicant
- Lauten, Alexander, et al., “Experimental Evaluation of the JenaClip Transcatheter Aortic Valve,” Catheterization and Cardiovascular Interventions 74:514-519, published online May 11, 2009, Applicant believes this may have been available online as early as Apr. 27, 2009.Applicant
- Leon, Martin B., MD, et al., “Transcatheter Aortic Valve Replacement in Patients with Critical Aortic Stenosis: Rationale, Device Descriptions, Early Clinical Experiences, and Perspectives,” Semin. Thorac. Cardiovasc. Surg. 18:165-174, 2006 in 10 pages, Applicant believes this may have been available as early as the Summer of 2006.Applicant
- Lozonschi, Lucian, MD, et al., “Transapical Mitral Valved Stent Implantation,” Ann Thorac Surg 2008;86:745-8 in 4 pages, Applicant believes this may have been available as early as Sep. 2008.Applicant
- Lutter, G., et al.: “Transcatheter Mitral Valve Replacement—Early Animal Results,” Universitätsklinikum, Schleswig-Holstein, unknown publication date.Applicant
- Lutter, Georg, et al., “Off-Pump Transapical Mitral Valve Replacement,” European Journal of Cardio-thoracic Surgery 36 (2009) 124-128, Applicant believes this may have been available as early as Apr. 25, 2009.Applicant
- Ma, Liang, et al., “Double-Crowned Valved Stents for Off-Pump Mitral Valve Replacement,” European Journal of Cardio-thoracic Surgery 28 (2005) 194-199, Applicant believes this may have been available as early as Aug. 2005.Applicant
- Mack, Michael, M.D., “Antegrade Transcatheter Mitral valve Implantation: A Short-term Experience in Swine Model,” Applicant believes this may have been presented on May 2011 at TVT.Applicant
- Mack, Michael, M.D., “Antegrade Transcatheter Mitral valve Implantation: On-Going Experience in Swine Model,” Applicant believes this may have been presented on Nov. 2011 at TCT.Applicant
- Masson, Jean-Bernard, et al., “Percutaneous Treatment of Mitral Regurgitation,” Circulation: Cardiovascular Interventions, 2:140-146, Applicant believes this may have been available as early as Apr. 14, 2009.Applicant
- Ostrovsky, Gene, “A Trial of Zenith Fenestrated AAA Endovascular Graft Goes on,” medGadget, Aug. 1, 2008, available at: :http://www.medgadget.com/2008/08/a—trial—of—zenith—fenestrated—aaa—endovascular—graft—goes—on.html.Applicant
- Pluth, James R., M.D., et al., “Aortic and Mitral Valve Replacement with Cloth-Covered Braunwald-Cutter Prosthesis, A Three-Year Follow-up,” The Annals of Thoracic Surgery, vol. 20, No. 3, Sep. 1975, pp. 239-248.Applicant
- Quadri, Arshad M.D., “Transcatheter Mitral Valve Implantation (TMVI) (An Acute In Vivo Study),” Applicant believes this may have been presented on Sep. 22, 2010 at TCT.Applicant
- Ratz, J. Brent, “In3 Company Overview,” Jun. 24, 2009.Applicant
- Ratz, J. Brent, “LSI EMT Spotlight,” May 15, 2009.Applicant
- Ruiz, Carlos E., “Overview of Novel Transcatheter Valve Technologies,” Applicant believes this may have been presented on May 27, 2010 at EuroPCR.Applicant
- Seidel, Wolfgang, et al., “A Mitral Valve Prosthesis and a Study of Thrombosis on Heart Valves in Dogs,” JSR—vol. II, No. 3—May 1962, submitted for publication Oct. 9, 1961.Applicant
- Sondergaard, Lars, et al., “Transcatheter Mitral Valve Implantation: CardiAQ™,” Applicant believes this may have been presented at EuroPCR May 2013.Applicant
- Sondergaard, Lars, et al., “Transcatheter Mitral Valve Implantation: CardiAQ™,” Applicant believes this may have been presented at TCT Oct. 2013.Applicant
- Spillner, J. et al., “New Sutureless ‘Atrial-Mitral-Valve Prosthesis’ For Minimally Invasive Mitral Valve Therapy,” Textile Research Journal, 2010, in 7 pages, Applicant believes this may have been available as early as Aug. 9, 2010.Applicant
- Vu, Duc-Thang, MD, et al., “Novel Sutureless Mitral Valve Implantation Method Involving a Bayonet Insertion and Release Mechanism: A Proof of Concept Study in Pigs,” The Journal of Thoracic and Cardiovascular Surgery, vol. 143, No. 4, 985-988, Apr. 2012, Applicant believes this may have been available online as early as Feb. 11, 2012.Applicant
- Walther, Thomas et al., “Transapical Approach for Sutureless Stent-Fixed Aortic Valve Implantation: Experimental Results,” European Journal of Cardio-thoracic Surgery 29 (2006) 703-708, Applicant believes this may have been available as early as May 2006.Applicant
- Webb, John G., et al., “Transcatheter Aortic Valve Implantation: The Evolution of Prostheses, Delivery Systems and Approaches,” Archives of Cardiovascular Disease (2012) 105, 153-159, Applicant believes this may have been available as early as Mar. 16, 2012.Applicant
- Banai et al.: “Transapical Mitral Implantation of the Tiara Bioprosthesis,” JACC: Cardiovascular Interventions, vol. 7, No. 2, Feb. 2014:154-62.Applicant
- Bavaria, Joseph E. M.D. et al.: “Transcatheter Mitral Valve Implantation: The Future Gold Standard for MR?,” Applicant requests the Examiner to consider this reference to be prior art as of Dec. 2010.Applicant
- BioSpace, “CardiAQ Valve Technologies (CVT) Reports Cardiovascular Medicine Milestone: First-In-Humannonsurgical Percutaneous Implantation of a Bioprosthetic Mitral Heart Valve,” Jun. 14, 2012, p. 1, http://www.biospace.com/News/cardiaq-valve-technologies-cvt-reports/263900.Applicant
- Businesswire.com, “CardiAQ Valve Technologies (CVT) Discloses Successful Results of Acute In Vivo Study of Its Novel Transcatheter Mitral Valve Implantation (TMVI) System,” Sep. 28, 2009.Applicant
- Businesswire.com, CardiAQ Valve Technologies, “CardiAQ Valve Technologies (“CVT”) to disclose data during ‘EuroPCR 2010’ about the world's first successful in vivo transcatheter delivery of a mitral heart valve implant,” Irvine, California, May 20, 2010.Applicant
- CardiAQ Valve Technologies Company Fact Sheet 2009.Applicant
- Diagnostic and Interventional Cardiology, “Neovasc Announces Publication of Tiara Transcatheter Mitral Valve Preclinical Data in JACC,” Sep. 18, 2012, p. 1, http://www.dicardiology.com/content/neovasc-announces-publication-tiara-transcatheter-mitral-valve-preclinical-data-jacc.Applicant
- Diagnostic and Interventional Cardiology, “Neovasc Announces Successful Human Implant of Tiara Transcatheter Mitral Valve,” Feb. 18, 2014, p. 1, <http://www.dicardiology.com/article/neovasc-announces-successful-human-implant-tiara-transcatheter-mitral-valve>.Applicant
- Diagnostic and Interventional Cardiology, “Neovasc Receives First U.S. Patent for its Tiara Transcatheter Mitral Valve Replacement Technology,” Nov. 15, 2013, p. 1, <http://www.dicardiology.com/content/neovasc-receives-first-us-patent-its-tiara-transcatheter-mitral- valve-replacement-technology>.Applicant
- Feldman, Ted, MD. “Prospects for Percutaneous Valve Therapies,” Circulation 2007;116:2866-2877. Applicant believes that this may be available as early as Dec. 11, 2007.Applicant
- Grube, E. et al, “Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome.” J Am Coll Cardiol. Jul. 3, 2007;50(1):69-76. Epub Jun. 6, 2007.Applicant
- Horvath et al.: “Transapical Aortic Valve Replacement under Real-time Magnetic Resonance Imaging Guidance: Experimental Results with Balloon-Expandable and Self-Expanding Stents,” http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038190/. Jun. 2011.Applicant
- Mack, Michael M.D., “Advantages and Limitations of Surgical Mitral Valve Replacement; Lessons for the Transcatheter Approach,” Applicant believes this may have been available as early as Jun. 7, 2010. Applicant believes this may have been presented at the Texas Cardiovascular Innovative Ventures (TCIV) Conference in Dallas, TX on Dec. 8, 2010.Applicant
- Neovasc corporate presentation, Oct. 2009, available at http://www.neovasc.com/investors/documents/Neovasc-Corporate-Presentation-October-2009.pdf.Applicant
- Piazza, Nicoló, MD, et al., “Anatomy of the Aortic Valvar Complex and Its Implications for Transcatheter Implantation of the Aortic Valve,” Contemporary Reviews in Interventional Cardiology, Circ. Cardiovasc. Intervent., 2008;1:74-81, Applicant believes this may have been available as early as Aug. 2008.Applicant
- Ratz, J. Brent et al., “Any experiences making an expandable stent frame?” Arch-Pub.com, Architecture Forums: Modeling, Multiple forum postings from Feb. 3, 2009 to Feb. 4, 2009, http://www.arch-pub.com.Applicant
- Ratz, J. Brent et al., “Fabric, Skin, Cloth expansion . . . best approach?,” AREA by Autodesk, 3ds Max: Modeling, Forum postings from Feb. 18, 2009 to Feb. 19, 2009, http://area.autodesk.com.Applicant
- Ratz, J. Brent et al., “Isolating Interpolation,” Arch-Pub.com, Architecture Forums: Animation and Rigging, Forum postings from Feb. 9, 2009 to Feb. 10, 2009, http://www.arch-pub.com.Applicant
- Treede et al.: “Transapical transcatheter aortic valve implantation using the JenaValve™ system: acute and 30-day results of the multicentre CE-mark study.” http://ejcts.oxfordjournals.org/content/41/6/e131.long. Apr. 16, 2012.Applicant
- Van Mieghem, et al., “Anatomy of the Mitral Valvular Complez and Its Implications for Transcatheter Interventions for Mitral Regurgitation,” J. Am. Coll. Cardiol., 56:617-626 (Aug. 17, 2010).Applicant
- Wayback Machine, Neovasc Ostial Products Overview, https://web.archive.org/web/20090930050359/https://www.neovasc.com/vascular-products/ostialproducts/default.php, indicated as archived on Sep. 30, 2008.Applicant